![]()
Imported Disease Annotations - OMIMObject Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | PIGQ | Human | multiple congenital anomalies-hypotonia-seizures syndrome 4 | | IAGP | | 7240710 | | OMIM | | |
|
![]()
Imported Disease Annotations - OMIMObject Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | PIGQ | Human | multiple congenital anomalies-hypotonia-seizures syndrome 4 | | IAGP | | 7240710 | | OMIM | | |
|
|
|
|
|
|
|
|
|
|
# | Reference Title | Reference Citation |
1. | GOAs Human GO annotations | GOA_HUMAN data from the GO Consortium |
2. | KEGG Annotation Import Pipeline | Pipeline to import KEGG annotations from KEGG into RGD |
3. | ClinVar Automated Import and Annotation Pipeline | RGD automated import pipeline for ClinVar variants, variant-to-disease annotations and gene-to-disease annotations |
4. | Data Import for Chemical-Gene Interactions | RGD automated import pipeline for gene-chemical interactions |
5. | RGD HPO Phenotype Annotation Pipeline | RGD automated import pipeline for human HPO-to-gene-to-disease annotations |
PMID:9463366 | PMID:9729469 | PMID:10373468 | PMID:10944123 | PMID:11102867 | PMID:11157797 | PMID:11418246 | PMID:12477932 | PMID:14702039 | PMID:15231748 | PMID:15489334 | PMID:15616553 |
PMID:16162815 | PMID:16344560 | PMID:19851296 | PMID:20198315 | PMID:21873635 | PMID:22993228 | PMID:24463883 | PMID:25114068 | PMID:26186194 | PMID:28514442 | PMID:29117863 | PMID:32588908 |
PMID:33144569 | PMID:33961781 | PMID:36724073 | PMID:36736316 | PMID:37105505 |
PIGQ (Homo sapiens - human) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Pigq (Mus musculus - house mouse) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Pigq (Rattus norvegicus - Norway rat) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Pigq (Chinchilla lanigera - long-tailed chinchilla) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
PIGQ (Pan paniscus - bonobo/pygmy chimpanzee) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
PIGQ (Canis lupus familiaris - dog) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Pigq (Ictidomys tridecemlineatus - thirteen-lined ground squirrel) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
PIGQ (Sus scrofa - pig) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
PIGQ (Chlorocebus sabaeus - green monkey) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Pigq (Heterocephalus glaber - naked mole-rat) |
|
.
Variants in PIGQ
698 total Variants ![]() |
Name | Type | Condition(s) | Position(s) | Clinical significance |
NM_004204.5(PIGQ):c.556G>A (p.Val186Met) | single nucleotide variant | Epilepsy [RCV000530335] | Chr16:574630 [GRCh38] Chr16:624630 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.290G>T (p.Cys97Phe) | single nucleotide variant | Epilepsy [RCV000550247] | Chr16:574364 [GRCh38] Chr16:624364 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.1199_1201del (p.Tyr400del) | deletion | Developmental and epileptic encephalopathy, 77 [RCV000850141]|Epilepsy [RCV001240418]|Inborn genetic diseases [RCV000624078]|not provided [RCV000518905] | Chr16:578912..578914 [GRCh38] Chr16:628912..628914 [GRCh37] Chr16:16p13.3 |
pathogenic|likely pathogenic|uncertain significance |
NM_004204.5(PIGQ):c.34G>A (p.Val12Ile) | single nucleotide variant | Epilepsy [RCV000554015]|not provided [RCV004715252] | Chr16:574108 [GRCh38] Chr16:624108 [GRCh37] Chr16:16p13.3 |
benign |
NM_004204.5(PIGQ):c.1514G>A (p.Arg505Gln) | single nucleotide variant | Epilepsy [RCV000542907] | Chr16:580955 [GRCh38] Chr16:630955 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.75G>A (p.Pro25=) | single nucleotide variant | Epilepsy [RCV000544297]|PIGQ-related disorder [RCV003925581]|not provided [RCV004716521] | Chr16:574149 [GRCh38] Chr16:624149 [GRCh37] Chr16:16p13.3 |
benign |
NM_004204.5(PIGQ):c.400C>T (p.Arg134Cys) | single nucleotide variant | Epilepsy [RCV000542483]|not provided [RCV003333992] | Chr16:574474 [GRCh38] Chr16:624474 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.1253C>G (p.Ser418Cys) | single nucleotide variant | Epilepsy [RCV000530146] | Chr16:579098 [GRCh38] Chr16:629098 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.892G>A (p.Gly298Arg) | single nucleotide variant | Epilepsy [RCV000544645] | Chr16:576204 [GRCh38] Chr16:626204 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.350C>T (p.Ala117Val) | single nucleotide variant | Developmental and epileptic encephalopathy, 77 [RCV003224316]|Epilepsy [RCV000532331]|Inborn genetic diseases [RCV002528302]|PIGQ-related disorder [RCV004735595]|not provided [RCV002510912] | Chr16:574424 [GRCh38] Chr16:624424 [GRCh37] Chr16:16p13.3 |
benign|likely benign |
NM_004204.5(PIGQ):c.1568G>A (p.Gly523Asp) | single nucleotide variant | Epilepsy [RCV000551218]|PIGQ-related disorder [RCV003905326]|not provided [RCV004715251] | Chr16:582284 [GRCh38] Chr16:632284 [GRCh37] Chr16:16p13.3 |
benign |
NM_004204.5(PIGQ):c.236G>A (p.Arg79His) | single nucleotide variant | Epilepsy [RCV000525332] | Chr16:574310 [GRCh38] Chr16:624310 [GRCh37] Chr16:16p13.3 |
uncertain significance |
GRCh38/hg38 16p13.3-13.13(chr16:23141-11296695)x3 | copy number gain | See cases [RCV000052367] | Chr16:23141..11296695 [GRCh38] Chr16:73141..11390552 [GRCh37] Chr16:13141..11298053 [NCBI36] Chr16:16p13.3-13.13 |
pathogenic |
GRCh38/hg38 16p13.3(chr16:29941-2560460)x3 | copy number gain | See cases [RCV000052368] | Chr16:29941..2560460 [GRCh38] Chr16:79941..2610461 [GRCh37] Chr16:19941..2550462 [NCBI36] Chr16:16p13.3 |
pathogenic |
GRCh38/hg38 16p13.3(chr16:46566-1800860)x3 | copy number gain | See cases [RCV000052369] | Chr16:46566..1800860 [GRCh38] Chr16:96566..1850861 [GRCh37] Chr16:36566..1790862 [NCBI36] Chr16:16p13.3 |
pathogenic |
GRCh38/hg38 16p13.3(chr16:46766-3214623)x3 | copy number gain | See cases [RCV000052370] | Chr16:46766..3214623 [GRCh38] Chr16:96766..3264623 [GRCh37] Chr16:36766..3204624 [NCBI36] Chr16:16p13.3 |
pathogenic |
GRCh38/hg38 16p13.3(chr16:239680-589745)x3 | copy number gain | See cases [RCV000052371] | Chr16:239680..589745 [GRCh38] Chr16:289679..639745 [GRCh37] Chr16:229680..579746 [NCBI36] Chr16:16p13.3 |
pathogenic |
GRCh38/hg38 16p13.3(chr16:23141-1773349)x1 | copy number loss | See cases [RCV000053251] | Chr16:23141..1773349 [GRCh38] Chr16:73141..1823350 [GRCh37] Chr16:13141..1763351 [NCBI36] Chr16:16p13.3 |
pathogenic |
GRCh38/hg38 16p13.3(chr16:23141-1712523)x1 | copy number loss | See cases [RCV000053252] | Chr16:23141..1712523 [GRCh38] Chr16:73141..1762524 [GRCh37] Chr16:13141..1702525 [NCBI36] Chr16:16p13.3 |
pathogenic |
GRCh38/hg38 16p13.3(chr16:46766-1997582)x1 | copy number loss | See cases [RCV000053253] | Chr16:46766..1997582 [GRCh38] Chr16:96766..2047583 [GRCh37] Chr16:36766..1987584 [NCBI36] Chr16:16p13.3 |
pathogenic |
GRCh38/hg38 16p13.3(chr16:105429-1499893)x1 | copy number loss | See cases [RCV000053267] | Chr16:105429..1499893 [GRCh38] Chr16:155427..1549894 [GRCh37] Chr16:95427..1489895 [NCBI36] Chr16:16p13.3 |
pathogenic |
NM_004204.3(PIGQ):c.1141C>T (p.Leu381=) | single nucleotide variant | Malignant melanoma [RCV000071172] | Chr16:578856 [GRCh38] Chr16:628856 [GRCh37] Chr16:568857 [NCBI36] Chr16:16p13.3 |
not provided |
NM_004204.5(PIGQ):c.208C>T (p.Arg70Trp) | single nucleotide variant | Epilepsy [RCV001303329] | Chr16:574282 [GRCh38] Chr16:624282 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.690-2A>G | single nucleotide variant | Developmental and epileptic encephalopathy, 77 [RCV000128637] | Chr16:575837 [GRCh38] Chr16:625837 [GRCh37] Chr16:16p13.3 |
pathogenic|uncertain significance |
GRCh38/hg38 16p13.3-13.13(chr16:46766-11525516)x3 | copy number gain | See cases [RCV000133780] | Chr16:46766..11525516 [GRCh38] Chr16:96766..11619372 [GRCh37] Chr16:36766..11526873 [NCBI36] Chr16:16p13.3-13.13 |
pathogenic |
GRCh38/hg38 16p13.3(chr16:46766-1544014)x1 | copy number loss | See cases [RCV000134917] | Chr16:46766..1544014 [GRCh38] Chr16:96766..1594015 [GRCh37] Chr16:36766..1534016 [NCBI36] Chr16:16p13.3 |
pathogenic |
GRCh38/hg38 16p13.3(chr16:551385-722554)x3 | copy number gain | See cases [RCV000135264] | Chr16:551385..722554 [GRCh38] Chr16:601385..772554 [GRCh37] Chr16:541386..712555 [NCBI36] Chr16:16p13.3 |
likely benign |
GRCh38/hg38 16p13.3(chr16:46766-4247185)x3 | copy number gain | See cases [RCV000136687] | Chr16:46766..4247185 [GRCh38] Chr16:96766..4297186 [GRCh37] Chr16:36766..4237187 [NCBI36] Chr16:16p13.3 |
pathogenic |
GRCh38/hg38 16p13.3(chr16:46722-1867327)x1 | copy number loss | See cases [RCV000137826] | Chr16:46722..1867327 [GRCh38] Chr16:96722..1917328 [GRCh37] Chr16:36722..1857329 [NCBI36] Chr16:16p13.3 |
pathogenic |
GRCh38/hg38 16p13.3(chr16:46766-882211)x1 | copy number loss | See cases [RCV000137979] | Chr16:46766..882211 [GRCh38] Chr16:96766..932211 [GRCh37] Chr16:36766..872212 [NCBI36] Chr16:16p13.3 |
pathogenic|uncertain significance |
GRCh38/hg38 16p13.3(chr16:412341-925326)x3 | copy number gain | See cases [RCV000139354] | Chr16:412341..925326 [GRCh38] Chr16:462341..975326 [GRCh37] Chr16:402342..915327 [NCBI36] Chr16:16p13.3 |
uncertain significance |
GRCh38/hg38 16p13.3-13.12(chr16:43732-13326806)x3 | copy number gain | See cases [RCV000139166] | Chr16:43732..13326806 [GRCh38] Chr16:93732..13420663 [GRCh37] Chr16:33732..13328164 [NCBI36] Chr16:16p13.3-13.12 |
pathogenic |
GRCh38/hg38 16p13.3(chr16:534395-722554)x3 | copy number gain | See cases [RCV000140349] | Chr16:534395..722554 [GRCh38] Chr16:584395..772554 [GRCh37] Chr16:524396..712555 [NCBI36] Chr16:16p13.3 |
benign |
GRCh38/hg38 16p13.3(chr16:59980-1221651)x1 | copy number loss | See cases [RCV000141384] | Chr16:59980..1221651 [GRCh38] Chr16:109978..1271651 [GRCh37] Chr16:49978..1211652 [NCBI36] Chr16:16p13.3 |
pathogenic |
GRCh38/hg38 16p13.3(chr16:35880-605262)x1 | copy number loss | See cases [RCV000143709] | Chr16:35880..605262 [GRCh38] Chr16:85880..655262 [GRCh37] Chr16:25880..595263 [NCBI36] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.619C>T (p.Arg207Ter) | single nucleotide variant | Developmental and epileptic encephalopathy, 77 [RCV000850139]|Epilepsy [RCV002516438]|Global developmental delay [RCV000162174] | Chr16:574693 [GRCh38] Chr16:624693 [GRCh37] Chr16:16p13.3 |
pathogenic|likely pathogenic |
GRCh37/hg19 16p13.3(chr16:450686-1007236)x3 | copy number gain | See cases [RCV000239842] | Chr16:450686..1007236 [GRCh37] Chr16:16p13.3 |
uncertain significance |
GRCh37/hg19 16p13.3-11.2(chr16:102839-28327676)x3 | copy number gain | See cases [RCV000203445] | Chr16:102839..28327676 [GRCh37] Chr16:16p13.3-11.2 |
pathogenic |
NM_004204.5(PIGQ):c.1291G>A (p.Val431Ile) | single nucleotide variant | Epilepsy [RCV000544898]|Inborn genetic diseases [RCV004023744]|not provided [RCV002060294] | Chr16:579136 [GRCh38] Chr16:629136 [GRCh37] Chr16:16p13.3 |
likely benign|uncertain significance |
NM_004204.5(PIGQ):c.613G>T (p.Ala205Ser) | single nucleotide variant | Epilepsy [RCV000545078]|Inborn genetic diseases [RCV003258855] | Chr16:574687 [GRCh38] Chr16:624687 [GRCh37] Chr16:16p13.3 |
uncertain significance |
GRCh37/hg19 16p13.3(chr16:97494-1257060)x3 | copy number gain | Breast ductal adenocarcinoma [RCV000207237] | Chr16:97494..1257060 [GRCh37] Chr16:16p13.3 |
uncertain significance |
GRCh37/hg19 16p13.3(chr16:324072-705832)x3 | copy number gain | Breast ductal adenocarcinoma [RCV000207302] | Chr16:324072..705832 [GRCh37] Chr16:16p13.3 |
uncertain significance |
GRCh37/hg19 16p13.3(chr16:88165-1715454)x1 | copy number loss | See cases [RCV000239415] | Chr16:88165..1715454 [GRCh37] Chr16:16p13.3 |
pathogenic |
NM_004204.5(PIGQ):c.942+1G>A | single nucleotide variant | Developmental and epileptic encephalopathy, 77 [RCV001290116]|Epilepsy [RCV000537621]|Inborn genetic diseases [RCV002527652]|PIGQ-related disorder [RCV000787940]|not provided [RCV000518843] | Chr16:576255 [GRCh38] Chr16:626255 [GRCh37] Chr16:16p13.3 |
pathogenic|likely pathogenic|uncertain significance |
NM_004204.5(PIGQ):c.996C>T (p.Ala332=) | single nucleotide variant | Epilepsy [RCV000548397]|PIGQ-related disorder [RCV003960253]|not provided [RCV003333993] | Chr16:578432 [GRCh38] Chr16:628432 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.690-3C>T | single nucleotide variant | Epilepsy [RCV000529537] | Chr16:575836 [GRCh38] Chr16:625836 [GRCh37] Chr16:16p13.3 |
uncertain significance |
GRCh37/hg19 16p13.3(chr16:72769-1511716)x1 | copy number loss | See cases [RCV000240294] | Chr16:72769..1511716 [GRCh37] Chr16:16p13.3 |
pathogenic |
NM_004204.5(PIGQ):c.473G>A (p.Ser158Asn) | single nucleotide variant | Epilepsy [RCV000552038] | Chr16:574547 [GRCh38] Chr16:624547 [GRCh37] Chr16:16p13.3 |
uncertain significance |
GRCh37/hg19 16p13.3(chr16:239130-841725)x3 | copy number gain | See cases [RCV000240506] | Chr16:239130..841725 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.943-77A>G | single nucleotide variant | Developmental and epileptic encephalopathy, 77 [RCV001544400]|not provided [RCV001658277]|not specified [RCV004598024] | Chr16:578302 [GRCh38] Chr16:628302 [GRCh37] Chr16:16p13.3 |
benign |
NM_004204.5(PIGQ):c.1336-94C>T | single nucleotide variant | Developmental and epileptic encephalopathy, 77 [RCV001544402]|not provided [RCV001694081]|not specified [RCV004594349] | Chr16:580089 [GRCh38] Chr16:630089 [GRCh37] Chr16:16p13.3 |
benign |
NM_004204.5(PIGQ):c.1416+104C>T | single nucleotide variant | Developmental and epileptic encephalopathy, 77 [RCV001544403]|not provided [RCV001615282]|not specified [RCV004594350] | Chr16:580367 [GRCh38] Chr16:630367 [GRCh37] Chr16:16p13.3 |
benign |
NM_004204.5(PIGQ):c.1416+142T>G | single nucleotide variant | Developmental and epileptic encephalopathy, 77 [RCV001544404]|not provided [RCV001647410] | Chr16:580405 [GRCh38] Chr16:630405 [GRCh37] Chr16:16p13.3 |
benign |
NM_004204.5(PIGQ):c.1532-133G>A | single nucleotide variant | Developmental and epileptic encephalopathy, 77 [RCV001544406]|not provided [RCV001685497] | Chr16:582115 [GRCh38] Chr16:632115 [GRCh37] Chr16:16p13.3 |
benign |
NM_004204.5(PIGQ):c.1532-68G>C | single nucleotide variant | Developmental and epileptic encephalopathy, 77 [RCV001544510]|not provided [RCV001673183]|not specified [RCV004594352] | Chr16:582180 [GRCh38] Chr16:632180 [GRCh37] Chr16:16p13.3 |
benign |
NM_004204.5(PIGQ):c.1592A>C (p.Gln531Pro) | single nucleotide variant | not provided [RCV000489571] | Chr16:582308 [GRCh38] Chr16:632308 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.1532-23T>C | single nucleotide variant | Developmental and epileptic encephalopathy, 77 [RCV001544034]|not provided [RCV001685487]|not specified [RCV004594346] | Chr16:582225 [GRCh38] Chr16:632225 [GRCh37] Chr16:16p13.3 |
benign |
NM_004204.5(PIGQ):c.225G>A (p.Glu75=) | single nucleotide variant | Epilepsy [RCV000549889] | Chr16:574299 [GRCh38] Chr16:624299 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.295G>A (p.Glu99Lys) | single nucleotide variant | Epilepsy [RCV000528533] | Chr16:574369 [GRCh38] Chr16:624369 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.1505G>A (p.Arg502Gln) | single nucleotide variant | Epilepsy [RCV000532728]|PIGQ-related disorder [RCV003925580]|not provided [RCV002263733] | Chr16:580946 [GRCh38] Chr16:630946 [GRCh37] Chr16:16p13.3 |
likely benign|uncertain significance |
NM_004204.5(PIGQ):c.1485G>A (p.Pro495=) | single nucleotide variant | Epilepsy [RCV000559559]|not provided [RCV003884597] | Chr16:580926 [GRCh38] Chr16:630926 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.165C>T (p.Ala55=) | single nucleotide variant | Epilepsy [RCV000535136] | Chr16:574239 [GRCh38] Chr16:624239 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.620G>A (p.Arg207Gln) | single nucleotide variant | Epilepsy [RCV000560318]|not provided [RCV004568727] | Chr16:574694 [GRCh38] Chr16:624694 [GRCh37] Chr16:16p13.3 |
benign |
NM_004204.5(PIGQ):c.1209C>T (p.Tyr403=) | single nucleotide variant | Epilepsy [RCV000556373]|PIGQ-related disorder [RCV003905325]|not provided [RCV003389812] | Chr16:578924 [GRCh38] Chr16:628924 [GRCh37] Chr16:16p13.3 |
likely benign |
GRCh37/hg19 16p13.3(chr16:85880-754083)x1 | copy number loss | See cases [RCV000446474] | Chr16:85880..754083 [GRCh37] Chr16:16p13.3 |
pathogenic |
GRCh37/hg19 16p13.3-q24.3(chr16:69193-90274381)x3 | copy number gain | See cases [RCV000446684] | Chr16:69193..90274381 [GRCh37] Chr16:16p13.3-q24.3 |
pathogenic |
GRCh37/hg19 16p13.3-13.2(chr16:78801-9169448) | copy number gain | See cases [RCV000446555] | Chr16:78801..9169448 [GRCh37] Chr16:16p13.3-13.2 |
pathogenic |
GRCh37/hg19 16p13.3(chr16:97133-5122974)x3 | copy number gain | See cases [RCV000445663] | Chr16:97133..5122974 [GRCh37] Chr16:16p13.3 |
pathogenic |
GRCh37/hg19 16p13.3(chr16:106859-735154)x3 | copy number gain | See cases [RCV000511218] | Chr16:106859..735154 [GRCh37] Chr16:16p13.3 |
uncertain significance |
GRCh37/hg19 16p13.3(chr16:85880-643107)x1 | copy number loss | See cases [RCV000510746] | Chr16:85880..643107 [GRCh37] Chr16:16p13.3 |
pathogenic |
NM_004204.5(PIGQ):c.1274G>T (p.Arg425Leu) | single nucleotide variant | Epilepsy [RCV000630801] | Chr16:579119 [GRCh38] Chr16:629119 [GRCh37] Chr16:16p13.3 |
likely benign |
NC_000016.10:g.(?_578765)_(579200_?)del | deletion | Epilepsy [RCV000630802] | Chr16:578765..579200 [GRCh38] Chr16:628765..629200 [GRCh37] Chr16:16p13.3 |
pathogenic|uncertain significance |
NM_004204.5(PIGQ):c.752G>A (p.Arg251Gln) | single nucleotide variant | Epilepsy [RCV000630797]|Inborn genetic diseases [RCV004955723]|PIGQ-related disorder [RCV003980217] | Chr16:575901 [GRCh38] Chr16:625901 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.322G>A (p.Glu108Lys) | single nucleotide variant | Epilepsy [RCV000539259] | Chr16:574396 [GRCh38] Chr16:624396 [GRCh37] Chr16:16p13.3 |
benign |
NM_004204.5(PIGQ):c.91G>A (p.Val31Met) | single nucleotide variant | Developmental and epileptic encephalopathy, 77 [RCV001803903]|Epilepsy [RCV000630780]|Inborn genetic diseases [RCV002528845]|not provided [RCV002293466] | Chr16:574165 [GRCh38] Chr16:624165 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.1020G>A (p.Leu340=) | single nucleotide variant | Epilepsy [RCV000630792] | Chr16:578456 [GRCh38] Chr16:628456 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.486G>C (p.Leu162=) | single nucleotide variant | Epilepsy [RCV000630795] | Chr16:574560 [GRCh38] Chr16:624560 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.849G>T (p.Leu283=) | single nucleotide variant | Epilepsy [RCV000630800]|PIGQ-related disorder [RCV003953109]|not provided [RCV003392469] | Chr16:576161 [GRCh38] Chr16:626161 [GRCh37] Chr16:16p13.3 |
benign |
NM_004204.5(PIGQ):c.1546C>A (p.Arg516Ser) | single nucleotide variant | Epilepsy [RCV000535916]|not provided [RCV003222017] | Chr16:582262 [GRCh38] Chr16:632262 [GRCh37] Chr16:16p13.3 |
likely benign |
GRCh37/hg19 16p13.3-13.2(chr16:85880-9883129)x3 | copy number gain | See cases [RCV000510698] | Chr16:85880..9883129 [GRCh37] Chr16:16p13.3-13.2 |
pathogenic |
GRCh37/hg19 16p13.3-12.2(chr16:85880-22442007)x3 | copy number gain | See cases [RCV000511360] | Chr16:85880..22442007 [GRCh37] Chr16:16p13.3-12.2 |
pathogenic |
GRCh37/hg19 16p13.3-12.3(chr16:85880-19806921)x3 | copy number gain | See cases [RCV000512194] | Chr16:85880..19806921 [GRCh37] Chr16:16p13.3-12.3 |
pathogenic |
NM_004204.5(PIGQ):c.634A>C (p.Ile212Leu) | single nucleotide variant | Epilepsy [RCV000630783]|Inborn genetic diseases [RCV004025390] | Chr16:574708 [GRCh38] Chr16:624708 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.689G>A (p.Arg230Gln) | single nucleotide variant | Epilepsy [RCV000630785] | Chr16:574763 [GRCh38] Chr16:624763 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.1302G>T (p.Gln434His) | single nucleotide variant | Epilepsy [RCV000630787] | Chr16:579147 [GRCh38] Chr16:629147 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.183C>T (p.Ala61=) | single nucleotide variant | Epilepsy [RCV000630789] | Chr16:574257 [GRCh38] Chr16:624257 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.1617C>T (p.Arg539=) | single nucleotide variant | Epilepsy [RCV000556811]|not provided [RCV003392364] | Chr16:582906 [GRCh38] Chr16:632906 [GRCh37] Chr16:16p13.3 |
benign|likely benign |
NM_004204.5(PIGQ):c.915G>C (p.Leu305=) | single nucleotide variant | Epilepsy [RCV000534417]|not provided [RCV001675913] | Chr16:576227 [GRCh38] Chr16:626227 [GRCh37] Chr16:16p13.3 |
benign |
GRCh37/hg19 16p13.3-q24.3(chr16:85881-90155062) | copy number gain | See cases [RCV000511296] | Chr16:85881..90155062 [GRCh37] Chr16:16p13.3-q24.3 |
pathogenic |
GRCh37/hg19 16p13.3-q24.3(chr16:85881-90155062)x3 | copy number gain | See cases [RCV000512138] | Chr16:85881..90155062 [GRCh37] Chr16:16p13.3-q24.3 |
pathogenic |
NM_004204.5(PIGQ):c.1117G>A (p.Val373Met) | single nucleotide variant | Epilepsy [RCV000630775]|Inborn genetic diseases [RCV002528844]|not provided [RCV002060713] | Chr16:578832 [GRCh38] Chr16:628832 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.1571G>A (p.Arg524Lys) | single nucleotide variant | Epilepsy [RCV000630782]|PIGQ-related disorder [RCV003953107] | Chr16:582287 [GRCh38] Chr16:632287 [GRCh37] Chr16:16p13.3 |
likely benign|uncertain significance |
NM_004204.5(PIGQ):c.41C>T (p.Thr14Met) | single nucleotide variant | Epilepsy [RCV000630796]|Inborn genetic diseases [RCV003258893]|PIGQ-related disorder [RCV003928051]|not provided [RCV003392468] | Chr16:574115 [GRCh38] Chr16:624115 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.676G>A (p.Val226Ile) | single nucleotide variant | Epilepsy [RCV000630779]|Inborn genetic diseases [RCV004025389] | Chr16:574750 [GRCh38] Chr16:624750 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.477G>A (p.Thr159=) | single nucleotide variant | Epilepsy [RCV000630790]|PIGQ-related disorder [RCV004735686] | Chr16:574551 [GRCh38] Chr16:624551 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.918C>T (p.Ala306=) | single nucleotide variant | Epilepsy [RCV000559310]|PIGQ-related disorder [RCV003942726]|not provided [RCV003389813] | Chr16:576230 [GRCh38] Chr16:626230 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.1517C>T (p.Pro506Leu) | single nucleotide variant | Epilepsy [RCV000557604] | Chr16:580958 [GRCh38] Chr16:630958 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.968_969del (p.Leu323fs) | deletion | Developmental and epileptic encephalopathy, 77 [RCV000850140]|Epilepsy [RCV000816707]|Inborn genetic diseases [RCV000623033] | Chr16:578404..578405 [GRCh38] Chr16:628404..628405 [GRCh37] Chr16:16p13.3 |
pathogenic|uncertain significance |
NM_004204.5(PIGQ):c.335G>A (p.Arg112Gln) | single nucleotide variant | Epilepsy [RCV000630774]|Inborn genetic diseases [RCV004955722] | Chr16:574409 [GRCh38] Chr16:624409 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.1685G>A (p.Arg562His) | single nucleotide variant | Epilepsy [RCV000630776]|Inborn genetic diseases [RCV004659130] | Chr16:582974 [GRCh38] Chr16:632974 [GRCh37] Chr16:16p13.3 |
likely benign|uncertain significance |
NM_004204.5(PIGQ):c.1487T>C (p.Leu496Pro) | single nucleotide variant | Epilepsy [RCV000630784]|Inborn genetic diseases [RCV004025391] | Chr16:580928 [GRCh38] Chr16:630928 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.77A>G (p.Glu26Gly) | single nucleotide variant | Epilepsy [RCV000630786] | Chr16:574151 [GRCh38] Chr16:624151 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.925C>G (p.Leu309Val) | single nucleotide variant | Epilepsy [RCV000630793]|PIGQ-related disorder [RCV003953108]|not provided [RCV003392467] | Chr16:576237 [GRCh38] Chr16:626237 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.1116C>T (p.His372=) | single nucleotide variant | Epilepsy [RCV000630794]|not provided [RCV003222068] | Chr16:578831 [GRCh38] Chr16:628831 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.27G>A (p.Thr9=) | single nucleotide variant | Epilepsy [RCV000540049]|not provided [RCV004716520] | Chr16:574101 [GRCh38] Chr16:624101 [GRCh37] Chr16:16p13.3 |
benign |
NM_004204.5(PIGQ):c.810C>T (p.Ala270=) | single nucleotide variant | Epilepsy [RCV000558948]|PIGQ-related disorder [RCV003905327]|not provided [RCV004715253] | Chr16:575959 [GRCh38] Chr16:625959 [GRCh37] Chr16:16p13.3 |
benign |
NM_004204.5(PIGQ):c.885G>T (p.Trp295Cys) | single nucleotide variant | Epilepsy [RCV000630777] | Chr16:576197 [GRCh38] Chr16:626197 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.476C>T (p.Thr159Met) | single nucleotide variant | Epilepsy [RCV000630778] | Chr16:574550 [GRCh38] Chr16:624550 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.39_40delinsAG (p.Thr14Ala) | indel | Epilepsy [RCV000630781] | Chr16:574113..574114 [GRCh38] Chr16:624113..624114 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.1461C>T (p.Leu487=) | single nucleotide variant | Epilepsy [RCV000630788] | Chr16:580902 [GRCh38] Chr16:630902 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.429G>A (p.Leu143=) | single nucleotide variant | Epilepsy [RCV000630791]|PIGQ-related disorder [RCV003928050]|not provided [RCV004546537] | Chr16:574503 [GRCh38] Chr16:624503 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.1615C>T (p.Arg539Cys) | single nucleotide variant | Epilepsy [RCV000630798]|PIGQ-related disorder [RCV004735687]|not provided [RCV004705728] | Chr16:582904 [GRCh38] Chr16:632904 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.1557G>C (p.Arg519=) | single nucleotide variant | Epilepsy [RCV000630799] | Chr16:582273 [GRCh38] Chr16:632273 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.688C>T (p.Arg230Ter) | single nucleotide variant | Epilepsy [RCV000700963] | Chr16:574762 [GRCh38] Chr16:624762 [GRCh37] Chr16:16p13.3 |
pathogenic|uncertain significance |
GRCh37/hg19 16p13.3(chr16:85880-1498731)x1 | copy number loss | not provided [RCV000683740] | Chr16:85880..1498731 [GRCh37] Chr16:16p13.3 |
pathogenic |
GRCh37/hg19 16p13.3(chr16:85880-3216551)x3 | copy number gain | not provided [RCV000683742] | Chr16:85880..3216551 [GRCh37] Chr16:16p13.3 |
pathogenic |
GRCh37/hg19 16p13.3(chr16:85880-1875694)x1 | copy number loss | not provided [RCV000683741] | Chr16:85880..1875694 [GRCh37] Chr16:16p13.3 |
pathogenic |
GRCh37/hg19 16p13.3-13.13(chr16:85880-11209288)x3 | copy number gain | not provided [RCV000683743] | Chr16:85880..11209288 [GRCh37] Chr16:16p13.3-13.13 |
pathogenic |
NM_004204.5(PIGQ):c.643C>G (p.Leu215Val) | single nucleotide variant | Epilepsy [RCV000698905] | Chr16:574717 [GRCh38] Chr16:624717 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.242T>C (p.Leu81Pro) | single nucleotide variant | Epilepsy [RCV000701100] | Chr16:574316 [GRCh38] Chr16:624316 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.919G>A (p.Asp307Asn) | single nucleotide variant | Epilepsy [RCV000702138]|Inborn genetic diseases [RCV002533647] | Chr16:576231 [GRCh38] Chr16:626231 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.74C>T (p.Pro25Leu) | single nucleotide variant | Epilepsy [RCV000687967] | Chr16:574148 [GRCh38] Chr16:624148 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NC_000016.10:g.(?_582883)_(648190_?)del | deletion | Epilepsy [RCV000708134] | Chr16:582883..648190 [GRCh38] Chr16:632883..698190 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.1631dup (p.Tyr544Ter) | duplication | Epilepsy [RCV000699180] | Chr16:582919..582920 [GRCh38] Chr16:632919..632920 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.1130C>T (p.Ala377Val) | single nucleotide variant | Epilepsy [RCV000694259] | Chr16:578845 [GRCh38] Chr16:628845 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.1730G>A (p.Gly577Glu) | single nucleotide variant | Epilepsy [RCV000692181] | Chr16:583019 [GRCh38] Chr16:633019 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.1223+6C>T | single nucleotide variant | Epilepsy [RCV000700260] | Chr16:578944 [GRCh38] Chr16:628944 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.1634G>A (p.Arg545His) | single nucleotide variant | Epilepsy [RCV000686800] | Chr16:582923 [GRCh38] Chr16:632923 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.1438G>A (p.Val480Met) | single nucleotide variant | Epilepsy [RCV000697455]|Inborn genetic diseases [RCV002533487] | Chr16:580879 [GRCh38] Chr16:630879 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.1675G>A (p.Ala559Thr) | single nucleotide variant | Epilepsy [RCV000697469]|Inborn genetic diseases [RCV003243264] | Chr16:582964 [GRCh38] Chr16:632964 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.1454A>G (p.His485Arg) | single nucleotide variant | Epilepsy [RCV000687610]|Inborn genetic diseases [RCV004026269] | Chr16:580895 [GRCh38] Chr16:630895 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.902G>A (p.Arg301His) | single nucleotide variant | Epilepsy [RCV000696585]|Inborn genetic diseases [RCV002533458]|not provided [RCV003326491] | Chr16:576214 [GRCh38] Chr16:626214 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.1628C>G (p.Thr543Ser) | single nucleotide variant | Epilepsy [RCV000686984]|Inborn genetic diseases [RCV004026254] | Chr16:582917 [GRCh38] Chr16:632917 [GRCh37] Chr16:16p13.3 |
likely benign|uncertain significance |
NM_004204.5(PIGQ):c.821+3G>A | single nucleotide variant | Epilepsy [RCV000692218] | Chr16:575973 [GRCh38] Chr16:625973 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.1345G>A (p.Gly449Arg) | single nucleotide variant | not provided [RCV000714595] | Chr16:580192 [GRCh38] Chr16:630192 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.-9-1501A>G | single nucleotide variant | Developmental and epileptic encephalopathy, 77 [RCV001544396]|not provided [RCV004715503]|not specified [RCV004594347] | Chr16:572565 [GRCh38] Chr16:572565..572566 [GRCh38] Chr16:622565 [GRCh37] Chr16:622565..622566 [GRCh37] Chr16:16p13.3 |
benign |
GRCh37/hg19 16p13.3-q24.3(chr16:88165-90163275)x3 | copy number gain | not provided [RCV000738917] | Chr16:88165..90163275 [GRCh37] Chr16:16p13.3-q24.3 |
pathogenic |
GRCh37/hg19 16p13.3-q24.3(chr16:88165-90274695)x3 | copy number gain | not provided [RCV000738918] | Chr16:88165..90274695 [GRCh37] Chr16:16p13.3-q24.3 |
pathogenic |
GRCh37/hg19 16p13.3-q24.3(chr16:61451-90294632)x3 | copy number gain | not provided [RCV000738915] | Chr16:61451..90294632 [GRCh37] Chr16:16p13.3-q24.3 |
pathogenic |
GRCh37/hg19 16p13.3(chr16:591586-642610)x1 | copy number loss | not provided [RCV000738947] | Chr16:591586..642610 [GRCh37] Chr16:16p13.3 |
benign |
GRCh37/hg19 16p13.3(chr16:591586-784800)x3 | copy number gain | not provided [RCV000738948] | Chr16:591586..784800 [GRCh37] Chr16:16p13.3 |
benign |
GRCh37/hg19 16p13.3(chr16:593277-623238)x4 | copy number gain | not provided [RCV000738949] | Chr16:593277..623238 [GRCh37] Chr16:16p13.3 |
benign |
GRCh37/hg19 16p13.3(chr16:593277-640329)x3 | copy number gain | not provided [RCV000738950] | Chr16:593277..640329 [GRCh37] Chr16:16p13.3 |
benign |
GRCh37/hg19 16p13.3(chr16:593277-685708)x3 | copy number gain | not provided [RCV000738951] | Chr16:593277..685708 [GRCh37] Chr16:16p13.3 |
benign |
GRCh37/hg19 16p13.3(chr16:608264-633843)x3 | copy number gain | not provided [RCV000738952] | Chr16:608264..633843 [GRCh37] Chr16:16p13.3 |
benign |
GRCh37/hg19 16p13.3(chr16:610419-776308)x1 | copy number loss | not provided [RCV000738955] | Chr16:610419..776308 [GRCh37] Chr16:16p13.3 |
benign |
GRCh37/hg19 16p13.3(chr16:624108-780942)x3 | copy number gain | not provided [RCV000738956] | Chr16:624108..780942 [GRCh37] Chr16:16p13.3 |
benign |
GRCh37/hg19 16p13.3(chr16:624108-784800)x3 | copy number gain | not provided [RCV000738957] | Chr16:624108..784800 [GRCh37] Chr16:16p13.3 |
benign |
GRCh37/hg19 16p13.3(chr16:569754-781623)x3 | copy number gain | not provided [RCV000751474] | Chr16:569754..781623 [GRCh37] Chr16:16p13.3 |
benign |
GRCh37/hg19 16p13.3(chr16:569754-847743)x3 | copy number gain | not provided [RCV000751475] | Chr16:569754..847743 [GRCh37] Chr16:16p13.3 |
benign |
GRCh37/hg19 16p13.3(chr16:570466-781623)x3 | copy number gain | not provided [RCV000751476] | Chr16:570466..781623 [GRCh37] Chr16:16p13.3 |
benign |
GRCh37/hg19 16p13.3(chr16:572044-623238)x4 | copy number gain | not provided [RCV000751477] | Chr16:572044..623238 [GRCh37] Chr16:16p13.3 |
benign |
GRCh37/hg19 16p13.3(chr16:575312-700644)x3 | copy number gain | not provided [RCV000751478] | Chr16:575312..700644 [GRCh37] Chr16:16p13.3 |
benign |
GRCh37/hg19 16p13.3(chr16:580124-875402)x1 | copy number loss | not provided [RCV000751479] | Chr16:580124..875402 [GRCh37] Chr16:16p13.3 |
benign |
GRCh37/hg19 16p13.3(chr16:61451-1593645)x1 | copy number loss | not provided [RCV000751445] | Chr16:61451..1593645 [GRCh37] Chr16:16p13.3 |
pathogenic |
GRCh37/hg19 16p13.3(chr16:450309-951598)x3 | copy number gain | not provided [RCV000751466] | Chr16:450309..951598 [GRCh37] Chr16:16p13.3 |
benign |
GRCh37/hg19 16p13.3(chr16:569754-623238)x4 | copy number gain | not provided [RCV000751471] | Chr16:569754..623238 [GRCh37] Chr16:16p13.3 |
benign |
GRCh37/hg19 16p13.3(chr16:569754-700644)x4 | copy number gain | not provided [RCV000751472] | Chr16:569754..700644 [GRCh37] Chr16:16p13.3 |
benign |
GRCh37/hg19 16p13.3(chr16:569754-747013)x3 | copy number gain | not provided [RCV000751473] | Chr16:569754..747013 [GRCh37] Chr16:16p13.3 |
benign |
NM_004204.5(PIGQ):c.1335+265C>T | single nucleotide variant | not provided [RCV001669267] | Chr16:579445 [GRCh38] Chr16:629445 [GRCh37] Chr16:16p13.3 |
benign |
NM_004204.5(PIGQ):c.*318T>C | single nucleotide variant | not provided [RCV001693003]|not specified [RCV004594517] | Chr16:583353 [GRCh38] Chr16:633353 [GRCh37] Chr16:16p13.3 |
benign |
NM_004204.5(PIGQ):c.794A>G (p.Lys265Arg) | single nucleotide variant | Epilepsy [RCV001055080] | Chr16:575943 [GRCh38] Chr16:625943 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.1741G>A (p.Asp581Asn) | single nucleotide variant | Epilepsy [RCV001055936] | Chr16:583030 [GRCh38] Chr16:633030 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.946G>A (p.Val316Met) | single nucleotide variant | Epilepsy [RCV001056806] | Chr16:578382 [GRCh38] Chr16:628382 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.1594-184C>G | single nucleotide variant | not provided [RCV001690641] | Chr16:582699 [GRCh38] Chr16:632699 [GRCh37] Chr16:16p13.3 |
benign |
NM_004204.5(PIGQ):c.1674C>T (p.Gly558=) | single nucleotide variant | Epilepsy [RCV000878625]|Inborn genetic diseases [RCV002536800] | Chr16:582963 [GRCh38] Chr16:632963 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.970C>T (p.Leu324=) | single nucleotide variant | Epilepsy [RCV001428302] | Chr16:578406 [GRCh38] Chr16:628406 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.798G>A (p.Ala266=) | single nucleotide variant | Epilepsy [RCV000879170] | Chr16:575947 [GRCh38] Chr16:625947 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.1737G>A (p.Lys579=) | single nucleotide variant | Epilepsy [RCV003530114] | Chr16:583026 [GRCh38] Chr16:633026 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.498C>T (p.Phe166=) | single nucleotide variant | Epilepsy [RCV000949152] | Chr16:574572 [GRCh38] Chr16:624572 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.805C>T (p.Pro269Ser) | single nucleotide variant | Epilepsy [RCV001050516] | Chr16:575954 [GRCh38] Chr16:625954 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.445G>A (p.Asp149Asn) | single nucleotide variant | Epilepsy [RCV001044611]|not provided [RCV004693498] | Chr16:574519 [GRCh38] Chr16:624519 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.1421G>A (p.Arg474Gln) | single nucleotide variant | Epilepsy [RCV001046746]|Inborn genetic diseases [RCV004958400] | Chr16:580862 [GRCh38] Chr16:630862 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.1210G>A (p.Val404Ile) | single nucleotide variant | Epilepsy [RCV001047597]|Inborn genetic diseases [RCV002553166] | Chr16:578925 [GRCh38] Chr16:628925 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.1505G>T (p.Arg502Leu) | single nucleotide variant | Epilepsy [RCV001070320]|Inborn genetic diseases [RCV004960432] | Chr16:580946 [GRCh38] Chr16:630946 [GRCh37] Chr16:16p13.3 |
uncertain significance |
GRCh37/hg19 16p13.3(chr16:109978-4316797) | copy number gain | Chromosome 16p13.3 duplication syndrome [RCV000767731] | Chr16:109978..4316797 [GRCh37] Chr16:16p13.3 |
pathogenic |
NM_004204.5(PIGQ):c.564G>A (p.Leu188=) | single nucleotide variant | Epilepsy [RCV000916769] | Chr16:574638 [GRCh38] Chr16:624638 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.1650C>G (p.Gly550=) | single nucleotide variant | Epilepsy [RCV001400217] | Chr16:582939 [GRCh38] Chr16:632939 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.412C>T (p.Leu138=) | single nucleotide variant | Epilepsy [RCV000918409] | Chr16:574486 [GRCh38] Chr16:624486 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.120C>T (p.Phe40=) | single nucleotide variant | Epilepsy [RCV001416237] | Chr16:574194 [GRCh38] Chr16:624194 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.1447C>T (p.Leu483=) | single nucleotide variant | Epilepsy [RCV001485204] | Chr16:580888 [GRCh38] Chr16:630888 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.690-4G>A | single nucleotide variant | Epilepsy [RCV000879032] | Chr16:575835 [GRCh38] Chr16:625835 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.937G>A (p.Ala313Thr) | single nucleotide variant | Inborn genetic diseases [RCV003267545] | Chr16:576249 [GRCh38] Chr16:626249 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.529C>T (p.Arg177Cys) | single nucleotide variant | Epilepsy [RCV000818917] | Chr16:574603 [GRCh38] Chr16:624603 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.1530G>A (p.Ala510=) | single nucleotide variant | Epilepsy [RCV000820745] | Chr16:580971 [GRCh38] Chr16:630971 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.231G>A (p.Leu77=) | single nucleotide variant | Epilepsy [RCV001444472] | Chr16:574305 [GRCh38] Chr16:624305 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.1336-3C>T | single nucleotide variant | Epilepsy [RCV000814526] | Chr16:580180 [GRCh38] Chr16:630180 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.1555C>T (p.Arg519Trp) | single nucleotide variant | Epilepsy [RCV000794555] | Chr16:582271 [GRCh38] Chr16:632271 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.1628C>T (p.Thr543Ile) | single nucleotide variant | Epilepsy [RCV000816457]|not provided [RCV002469298] | Chr16:582917 [GRCh38] Chr16:632917 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.1531+3A>T | single nucleotide variant | Epilepsy [RCV000807022] | Chr16:580975 [GRCh38] Chr16:630975 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.178G>A (p.Val60Met) | single nucleotide variant | Epilepsy [RCV000791772] | Chr16:574252 [GRCh38] Chr16:624252 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.605C>T (p.Ala202Val) | single nucleotide variant | Epilepsy [RCV000821876] | Chr16:574679 [GRCh38] Chr16:624679 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.1546C>T (p.Arg516Cys) | single nucleotide variant | Epilepsy [RCV000816701]|not provided [RCV002293488] | Chr16:582262 [GRCh38] Chr16:632262 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.422T>C (p.Leu141Pro) | single nucleotide variant | Epilepsy [RCV000808558]|Inborn genetic diseases [RCV002537290] | Chr16:574496 [GRCh38] Chr16:624496 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.499G>A (p.Asp167Asn) | single nucleotide variant | Epilepsy [RCV000812781]|Inborn genetic diseases [RCV002537379] | Chr16:574573 [GRCh38] Chr16:624573 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.355G>A (p.Gly119Ser) | single nucleotide variant | Epilepsy [RCV000822148]|Inborn genetic diseases [RCV004958174]|not provided [RCV002292586] | Chr16:574429 [GRCh38] Chr16:624429 [GRCh37] Chr16:16p13.3 |
likely benign|uncertain significance |
NM_004204.5(PIGQ):c.1094_1095inv (p.Phe365Ter) | inversion | Epilepsy [RCV000813302] | Chr16:578809..578810 [GRCh38] Chr16:628809..628810 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.832A>G (p.Thr278Ala) | single nucleotide variant | Epilepsy [RCV000805867] | Chr16:576144 [GRCh38] Chr16:626144 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.1145C>T (p.Thr382Met) | single nucleotide variant | Epilepsy [RCV000809697] | Chr16:578860 [GRCh38] Chr16:628860 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.341C>T (p.Ala114Val) | single nucleotide variant | Epilepsy [RCV000812115] | Chr16:574415 [GRCh38] Chr16:624415 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.737C>T (p.Thr246Met) | single nucleotide variant | Epilepsy [RCV000817180] | Chr16:575886 [GRCh38] Chr16:625886 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.158G>A (p.Arg53Gln) | single nucleotide variant | Epilepsy [RCV000808085]|not provided [RCV001815480] | Chr16:574232 [GRCh38] Chr16:624232 [GRCh37] Chr16:16p13.3 |
likely benign|uncertain significance |
NM_004204.5(PIGQ):c.527T>C (p.Phe176Ser) | single nucleotide variant | Epilepsy [RCV000823995] | Chr16:574601 [GRCh38] Chr16:624601 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.65G>A (p.Arg22Gln) | single nucleotide variant | Developmental and epileptic encephalopathy, 77 [RCV001542280]|Epilepsy [RCV000810709]|Inborn genetic diseases [RCV002537339] | Chr16:574139 [GRCh38] Chr16:624139 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.618del (p.Arg206fs) | deletion | Epilepsy [RCV000798268] | Chr16:574691 [GRCh38] Chr16:624691 [GRCh37] Chr16:16p13.3 |
pathogenic|uncertain significance |
NM_004204.5(PIGQ):c.1717T>A (p.Trp573Arg) | single nucleotide variant | Epilepsy [RCV000811132] | Chr16:583006 [GRCh38] Chr16:633006 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.721G>A (p.Gly241Arg) | single nucleotide variant | Epilepsy [RCV000793681] | Chr16:575870 [GRCh38] Chr16:625870 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.1113G>A (p.Trp371Ter) | single nucleotide variant | Epilepsy [RCV000795788] | Chr16:578828 [GRCh38] Chr16:628828 [GRCh37] Chr16:16p13.3 |
pathogenic|uncertain significance |
NM_004204.5(PIGQ):c.874C>G (p.Leu292Val) | single nucleotide variant | Epilepsy [RCV000810870] | Chr16:576186 [GRCh38] Chr16:626186 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.943-3C>T | single nucleotide variant | Epilepsy [RCV000812229] | Chr16:578376 [GRCh38] Chr16:628376 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.49G>A (p.Gly17Arg) | single nucleotide variant | PIGQ-related disorder [RCV000788055] | Chr16:574123 [GRCh38] Chr16:624123 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.907G>A (p.Gly303Arg) | single nucleotide variant | Epilepsy [RCV000794552] | Chr16:576219 [GRCh38] Chr16:626219 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.1504C>T (p.Arg502Trp) | single nucleotide variant | Epilepsy [RCV000799710] | Chr16:580945 [GRCh38] Chr16:630945 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.604G>A (p.Ala202Thr) | single nucleotide variant | Epilepsy [RCV000794907]|Inborn genetic diseases [RCV003353024]|not provided [RCV001772049] | Chr16:574678 [GRCh38] Chr16:624678 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.1177G>A (p.Ala393Thr) | single nucleotide variant | Epilepsy [RCV000797521] | Chr16:578892 [GRCh38] Chr16:628892 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NC_000016.9:g.(?_624055)_(2115656_?)del | deletion | Tuberous sclerosis 2 [RCV000811345] | Chr16:624055..2115656 [GRCh37] Chr16:16p13.3 |
pathogenic |
NM_004204.5(PIGQ):c.1417-3C>T | single nucleotide variant | Epilepsy [RCV001056953] | Chr16:580855 [GRCh38] Chr16:630855 [GRCh37] Chr16:16p13.3 |
uncertain significance |
GRCh37/hg19 16p13.3(chr16:85880-830613)x1 | copy number loss | not provided [RCV000846660] | Chr16:85880..830613 [GRCh37] Chr16:16p13.3 |
pathogenic |
GRCh37/hg19 16p13.3(chr16:85880-2053328)x1 | copy number loss | not provided [RCV000849039] | Chr16:85880..2053328 [GRCh37] Chr16:16p13.3 |
pathogenic |
GRCh37/hg19 16p13.3(chr16:85880-1468459)x1 | copy number loss | not provided [RCV000848130] | Chr16:85880..1468459 [GRCh37] Chr16:16p13.3 |
pathogenic |
NM_004204.5(PIGQ):c.1430T>C (p.Val477Ala) | single nucleotide variant | Epilepsy [RCV001245573]|not provided [RCV002275324] | Chr16:580871 [GRCh38] Chr16:630871 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.1256C>T (p.Ser419Leu) | single nucleotide variant | Epilepsy [RCV001227233]|Inborn genetic diseases [RCV004032597] | Chr16:579101 [GRCh38] Chr16:629101 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.157C>T (p.Arg53Trp) | single nucleotide variant | Epilepsy [RCV001221157] | Chr16:574231 [GRCh38] Chr16:624231 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.1416+3G>A | single nucleotide variant | Epilepsy [RCV001227197] | Chr16:580266 [GRCh38] Chr16:630266 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.1166C>T (p.Ser389Leu) | single nucleotide variant | Epilepsy [RCV001218249]|not provided [RCV004695203] | Chr16:578881 [GRCh38] Chr16:628881 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.1382C>T (p.Pro461Leu) | single nucleotide variant | Epilepsy [RCV001235725]|Inborn genetic diseases [RCV002563836] | Chr16:580229 [GRCh38] Chr16:630229 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.913C>G (p.Leu305Val) | single nucleotide variant | Epilepsy [RCV001219029]|Inborn genetic diseases [RCV002562468] | Chr16:576225 [GRCh38] Chr16:626225 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.638_639delinsTT (p.Cys213Phe) | indel | Epilepsy [RCV001229569] | Chr16:574712..574713 [GRCh38] Chr16:624712..624713 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.1532-50T>A | single nucleotide variant | Developmental and epileptic encephalopathy, 77 [RCV001544033]|not provided [RCV001647397]|not specified [RCV004594345] | Chr16:582198 [GRCh38] Chr16:632198 [GRCh37] Chr16:16p13.3 |
benign |
NM_004204.5(PIGQ):c.*729G>A | single nucleotide variant | not provided [RCV001638610] | Chr16:583764 [GRCh38] Chr16:633764 [GRCh37] Chr16:16p13.3 |
benign |
NM_004204.5(PIGQ):c.1335+267A>G | single nucleotide variant | not provided [RCV001676145] | Chr16:579447 [GRCh38] Chr16:629447 [GRCh37] Chr16:16p13.3 |
benign |
NM_004204.5(PIGQ):c.1335+278A>G | single nucleotide variant | not provided [RCV001680041] | Chr16:579458 [GRCh38] Chr16:629458 [GRCh37] Chr16:16p13.3 |
benign |
NM_004204.5(PIGQ):c.1335+267_1335+338del | deletion | not provided [RCV001708008] | Chr16:579428..579499 [GRCh38] Chr16:629428..629499 [GRCh37] Chr16:16p13.3 |
benign |
NM_004204.5(PIGQ):c.1532-24G>A | single nucleotide variant | not provided [RCV001652892] | Chr16:582224 [GRCh38] Chr16:632224 [GRCh37] Chr16:16p13.3 |
benign |
NM_004204.5(PIGQ):c.1556G>A (p.Arg519Gln) | single nucleotide variant | Epilepsy [RCV000878310] | Chr16:582272 [GRCh38] Chr16:632272 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.1437C>T (p.Ala479=) | single nucleotide variant | Epilepsy [RCV000952185] | Chr16:580878 [GRCh38] Chr16:630878 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.616A>C (p.Arg206=) | single nucleotide variant | Epilepsy [RCV000952350] | Chr16:574690 [GRCh38] Chr16:624690 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.579G>A (p.Ser193=) | single nucleotide variant | Epilepsy [RCV000974802]|PIGQ-related disorder [RCV003953343] | Chr16:574653 [GRCh38] Chr16:624653 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.1602A>G (p.Pro534=) | single nucleotide variant | Epilepsy [RCV001485139]|Inborn genetic diseases [RCV002539282] | Chr16:582891 [GRCh38] Chr16:632891 [GRCh37] Chr16:16p13.3 |
likely benign|uncertain significance |
NM_004204.5(PIGQ):c.219C>T (p.Pro73=) | single nucleotide variant | Epilepsy [RCV000907423] | Chr16:574293 [GRCh38] Chr16:624293 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.690-5C>T | single nucleotide variant | Epilepsy [RCV001394000] | Chr16:575834 [GRCh38] Chr16:625834 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.1251G>A (p.Leu417=) | single nucleotide variant | Epilepsy [RCV002065608] | Chr16:579096 [GRCh38] Chr16:629096 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.1223+7G>A | single nucleotide variant | Epilepsy [RCV000909585] | Chr16:578945 [GRCh38] Chr16:628945 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.720C>T (p.Leu240=) | single nucleotide variant | Epilepsy [RCV001446127] | Chr16:575869 [GRCh38] Chr16:625869 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.943-5T>C | single nucleotide variant | Epilepsy [RCV000885827] | Chr16:578374 [GRCh38] Chr16:628374 [GRCh37] Chr16:16p13.3 |
likely benign |
NC_000016.9:g.(?_624055)_(2148005_?)del | deletion | Tuberous sclerosis 2 [RCV001033183] | Chr16:624055..2148005 [GRCh37] Chr16:16p13.3 |
pathogenic |
NM_004204.5(PIGQ):c.*671C>T | single nucleotide variant | not provided [RCV001643709] | Chr16:583706 [GRCh38] Chr16:633706 [GRCh37] Chr16:16p13.3 |
benign |
NM_004204.5(PIGQ):c.1633C>T (p.Arg545Cys) | single nucleotide variant | Epilepsy [RCV001203612] | Chr16:582922 [GRCh38] Chr16:632922 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.1462G>A (p.Val488Met) | single nucleotide variant | Epilepsy [RCV001203668] | Chr16:580903 [GRCh38] Chr16:630903 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.412C>G (p.Leu138Val) | single nucleotide variant | Epilepsy [RCV001245136] | Chr16:574486 [GRCh38] Chr16:624486 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.38C>G (p.Ser13Trp) | single nucleotide variant | Epilepsy [RCV001205935] | Chr16:574112 [GRCh38] Chr16:624112 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.1688A>G (p.Lys563Arg) | single nucleotide variant | Epilepsy [RCV001064531]|Inborn genetic diseases [RCV004030540] | Chr16:582977 [GRCh38] Chr16:632977 [GRCh37] Chr16:16p13.3 |
likely benign|uncertain significance |
NM_004204.5(PIGQ):c.1501C>T (p.Leu501Phe) | single nucleotide variant | Epilepsy [RCV000890948]|PIGQ-related disorder [RCV003940678]|not provided [RCV003235431] | Chr16:580942 [GRCh38] Chr16:630942 [GRCh37] Chr16:16p13.3 |
likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_004204.5(PIGQ):c.115C>T (p.Pro39Ser) | single nucleotide variant | Epilepsy [RCV003011690] | Chr16:574189 [GRCh38] Chr16:624189 [GRCh37] Chr16:16p13.3 |
uncertain significance |
GRCh37/hg19 16p13.3(chr16:85880-1166355)x1 | copy number loss | not provided [RCV001006741] | Chr16:85880..1166355 [GRCh37] Chr16:16p13.3 |
pathogenic |
GRCh37/hg19 16p13.3(chr16:364182-1186480)x3 | copy number gain | not provided [RCV001006744] | Chr16:364182..1186480 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.1336-158C>G | single nucleotide variant | not provided [RCV001595376] | Chr16:580025 [GRCh38] Chr16:630025 [GRCh37] Chr16:16p13.3 |
benign |
NM_004204.5(PIGQ):c.1532-175C>T | single nucleotide variant | not provided [RCV001597764] | Chr16:582073 [GRCh38] Chr16:632073 [GRCh37] Chr16:16p13.3 |
benign |
NM_004204.5(PIGQ):c.943-249A>G | single nucleotide variant | not provided [RCV001618929] | Chr16:578130 [GRCh38] Chr16:628130 [GRCh37] Chr16:16p13.3 |
benign |
NM_004204.5(PIGQ):c.1532-197T>C | single nucleotide variant | not provided [RCV001596198] | Chr16:582051 [GRCh38] Chr16:632051 [GRCh37] Chr16:16p13.3 |
benign |
NM_004204.5(PIGQ):c.1417-148A>G | single nucleotide variant | not provided [RCV001595702] | Chr16:580710 [GRCh38] Chr16:630710 [GRCh37] Chr16:16p13.3 |
benign |
NM_004204.5(PIGQ):c.1594-155T>C | single nucleotide variant | not provided [RCV001673558] | Chr16:582728 [GRCh38] Chr16:632728 [GRCh37] Chr16:16p13.3 |
benign |
NM_004204.5(PIGQ):c.1335+278_1335+349del | deletion | not provided [RCV001686517] | Chr16:579448..579519 [GRCh38] Chr16:629448..629519 [GRCh37] Chr16:16p13.3 |
benign |
NM_004204.5(PIGQ):c.*319G>A | single nucleotide variant | not provided [RCV001615840]|not specified [RCV004594387] | Chr16:583354 [GRCh38] Chr16:633354 [GRCh37] Chr16:16p13.3 |
benign |
NM_004204.5(PIGQ):c.194C>T (p.Thr65Ile) | single nucleotide variant | Epilepsy [RCV001061639] | Chr16:574268 [GRCh38] Chr16:624268 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.*808A>G | single nucleotide variant | not provided [RCV001669216] | Chr16:583843 [GRCh38] Chr16:633843 [GRCh37] Chr16:16p13.3 |
benign |
NM_004204.5(PIGQ):c.*90T>C | single nucleotide variant | not provided [RCV001668076]|not specified [RCV004594488] | Chr16:583125 [GRCh38] Chr16:633125 [GRCh37] Chr16:16p13.3 |
benign |
NM_004204.5(PIGQ):c.1532-237C>T | single nucleotide variant | not provided [RCV001666322] | Chr16:582011 [GRCh38] Chr16:632011 [GRCh37] Chr16:16p13.3 |
benign |
NM_004204.5(PIGQ):c.942+92A>C | single nucleotide variant | Developmental and epileptic encephalopathy, 77 [RCV001544399]|not provided [RCV001647409]|not specified [RCV004594348] | Chr16:576346 [GRCh38] Chr16:626346 [GRCh37] Chr16:16p13.3 |
benign |
NM_004204.5(PIGQ):c.1224-63C>T | single nucleotide variant | Developmental and epileptic encephalopathy, 77 [RCV001544401]|not provided [RCV001615281] | Chr16:579006 [GRCh38] Chr16:629006 [GRCh37] Chr16:16p13.3 |
benign |
NM_004204.5(PIGQ):c.1532-110C>T | single nucleotide variant | Developmental and epileptic encephalopathy, 77 [RCV001544407]|not provided [RCV001698679]|not specified [RCV004594351] | Chr16:582138 [GRCh38] Chr16:632138 [GRCh37] Chr16:16p13.3 |
benign |
NM_004204.5(PIGQ):c.*816T>C | single nucleotide variant | not provided [RCV001642063] | Chr16:583851 [GRCh38] Chr16:633851 [GRCh37] Chr16:16p13.3 |
benign |
NM_004204.5(PIGQ):c.1594-116A>G | single nucleotide variant | not provided [RCV001710045]|not specified [RCV004594538] | Chr16:582767 [GRCh38] Chr16:632767 [GRCh37] Chr16:16p13.3 |
benign |
NM_004204.5(PIGQ):c.82A>T (p.Ser28Cys) | single nucleotide variant | Epilepsy [RCV001206084]|Inborn genetic diseases [RCV002561212] | Chr16:574156 [GRCh38] Chr16:624156 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.1137G>A (p.Leu379=) | single nucleotide variant | Epilepsy [RCV001039281] | Chr16:578852 [GRCh38] Chr16:628852 [GRCh37] Chr16:16p13.3 |
likely benign|uncertain significance |
NM_004204.5(PIGQ):c.586G>A (p.Val196Met) | single nucleotide variant | Epilepsy [RCV001217484]|Inborn genetic diseases [RCV002562977] | Chr16:574660 [GRCh38] Chr16:624660 [GRCh37] Chr16:16p13.3 |
uncertain significance |
GRCh37/hg19 16p13.3(chr16:106988-735154)x3 | copy number gain | not provided [RCV001006742] | Chr16:106988..735154 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.184G>A (p.Val62Met) | single nucleotide variant | Epilepsy [RCV001035437] | Chr16:574258 [GRCh38] Chr16:624258 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.872T>C (p.Met291Thr) | single nucleotide variant | Epilepsy [RCV001211046] | Chr16:576184 [GRCh38] Chr16:626184 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.1151C>T (p.Ala384Val) | single nucleotide variant | Epilepsy [RCV001232771] | Chr16:578866 [GRCh38] Chr16:628866 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.512G>A (p.Arg171His) | single nucleotide variant | Epilepsy [RCV001046514]|Inborn genetic diseases [RCV003283892]|not provided [RCV001664641] | Chr16:574586 [GRCh38] Chr16:624586 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NC_000016.9:g.(?_624055)_(2550979_?)dup | duplication | Idiopathic generalized epilepsy [RCV001033790] | Chr16:624055..2550979 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.1417C>T (p.Leu473Phe) | single nucleotide variant | Epilepsy [RCV001211612] | Chr16:580858 [GRCh38] Chr16:630858 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.856G>A (p.Val286Met) | single nucleotide variant | Epilepsy [RCV001210772] | Chr16:576168 [GRCh38] Chr16:626168 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.1258C>G (p.Leu420Val) | single nucleotide variant | Epilepsy [RCV001204735] | Chr16:579103 [GRCh38] Chr16:629103 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.1537G>A (p.Val513Met) | single nucleotide variant | Epilepsy [RCV001228606] | Chr16:582253 [GRCh38] Chr16:632253 [GRCh37] Chr16:16p13.3 |
uncertain significance |
GRCh37/hg19 16p13.3(chr16:84485-5251013)x3 | copy number gain | not provided [RCV001537890] | Chr16:84485..5251013 [GRCh37] Chr16:16p13.3 |
pathogenic |
GRCh37/hg19 16p13.3(chr16:85880-5249457)x3 | copy number gain | not provided [RCV001259749] | Chr16:85880..5249457 [GRCh37] Chr16:16p13.3 |
pathogenic |
NM_004204.5(PIGQ):c.334C>T (p.Arg112Trp) | single nucleotide variant | Epilepsy [RCV001257261] | Chr16:574408 [GRCh38] Chr16:624408 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NC_000016.9:g.(?_632883)_(698190_?)del | deletion | Epilepsy [RCV001314118] | Chr16:632883..698190 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.797C>T (p.Ala266Val) | single nucleotide variant | Epilepsy [RCV001337152] | Chr16:575946 [GRCh38] Chr16:625946 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.751C>T (p.Arg251Trp) | single nucleotide variant | Epilepsy [RCV001349019] | Chr16:575900 [GRCh38] Chr16:625900 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.1528G>T (p.Ala510Ser) | single nucleotide variant | Epilepsy [RCV001337167] | Chr16:580969 [GRCh38] Chr16:630969 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.719T>C (p.Leu240Pro) | single nucleotide variant | Epilepsy [RCV001305723] | Chr16:575868 [GRCh38] Chr16:625868 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.530G>A (p.Arg177His) | single nucleotide variant | Developmental and epileptic encephalopathy, 77 [RCV004727096]|Epilepsy [RCV001299244] | Chr16:574604 [GRCh38] Chr16:624604 [GRCh37] Chr16:16p13.3 |
likely benign|uncertain significance |
NM_004204.5(PIGQ):c.1370T>G (p.Leu457Arg) | single nucleotide variant | Epilepsy [RCV001302799]|Inborn genetic diseases [RCV004036254] | Chr16:580217 [GRCh38] Chr16:630217 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.618G>C (p.Arg206Ser) | single nucleotide variant | Developmental and epileptic encephalopathy, 77 [RCV003483811]|Epilepsy [RCV001302514] | Chr16:574692 [GRCh38] Chr16:624692 [GRCh37] Chr16:16p13.3 |
uncertain significance|not provided |
NM_004204.5(PIGQ):c.856G>T (p.Val286Leu) | single nucleotide variant | Epilepsy [RCV001342779] | Chr16:576168 [GRCh38] Chr16:626168 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.1640C>G (p.Pro547Arg) | single nucleotide variant | Epilepsy [RCV001324978] | Chr16:582929 [GRCh38] Chr16:632929 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.1580G>A (p.Arg527His) | single nucleotide variant | Epilepsy [RCV001313668] | Chr16:582296 [GRCh38] Chr16:632296 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NC_000016.9:g.(?_624055)_(2153916_?)dup | duplication | Epilepsy [RCV001344085]|Idiopathic generalized epilepsy [RCV001316565] | Chr16:624055..2153916 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.1513C>T (p.Arg505Trp) | single nucleotide variant | Epilepsy [RCV001316350] | Chr16:580954 [GRCh38] Chr16:630954 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.332A>C (p.His111Pro) | single nucleotide variant | Epilepsy [RCV001369049] | Chr16:574406 [GRCh38] Chr16:624406 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.211C>T (p.Gln71Ter) | single nucleotide variant | Epilepsy [RCV001382377] | Chr16:574285 [GRCh38] Chr16:624285 [GRCh37] Chr16:16p13.3 |
pathogenic |
NM_004204.5(PIGQ):c.1162C>T (p.Leu388Phe) | single nucleotide variant | Epilepsy [RCV001371028] | Chr16:578877 [GRCh38] Chr16:628877 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.19T>G (p.Phe7Val) | single nucleotide variant | Epilepsy [RCV001362562]|Inborn genetic diseases [RCV004036842] | Chr16:574093 [GRCh38] Chr16:624093 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.1594-147T>C | single nucleotide variant | not provided [RCV001536484] | Chr16:582736 [GRCh38] Chr16:632736 [GRCh37] Chr16:16p13.3 |
benign |
NM_004204.5(PIGQ):c.560G>A (p.Arg187Gln) | single nucleotide variant | Epilepsy [RCV001371990] | Chr16:574634 [GRCh38] Chr16:624634 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.503C>T (p.Thr168Met) | single nucleotide variant | Developmental and epileptic encephalopathy, 77 [RCV003224561]|Epilepsy [RCV001373536] | Chr16:574577 [GRCh38] Chr16:624577 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.1560C>G (p.His520Gln) | single nucleotide variant | Epilepsy [RCV001323858] | Chr16:582276 [GRCh38] Chr16:632276 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.1561G>A (p.Glu521Lys) | single nucleotide variant | Epilepsy [RCV001369165] | Chr16:582277 [GRCh38] Chr16:632277 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.608A>C (p.Glu203Ala) | single nucleotide variant | Epilepsy [RCV001316510] | Chr16:574682 [GRCh38] Chr16:624682 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.538C>T (p.Arg180Cys) | single nucleotide variant | Epilepsy [RCV001359076]|not provided [RCV003389868] | Chr16:574612 [GRCh38] Chr16:624612 [GRCh37] Chr16:16p13.3 |
likely benign|uncertain significance |
NM_004204.5(PIGQ):c.220G>A (p.Glu74Lys) | single nucleotide variant | Epilepsy [RCV001312917] | Chr16:574294 [GRCh38] Chr16:624294 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.1618G>A (p.Val540Met) | single nucleotide variant | Epilepsy [RCV001373983]|Inborn genetic diseases [RCV004952853] | Chr16:582907 [GRCh38] Chr16:632907 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.148G>T (p.Ala50Ser) | single nucleotide variant | Epilepsy [RCV001345245]|Inborn genetic diseases [RCV003169668]|not provided [RCV001762583] | Chr16:574222 [GRCh38] Chr16:624222 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.23C>A (p.Pro8His) | single nucleotide variant | Epilepsy [RCV001363839] | Chr16:574097 [GRCh38] Chr16:624097 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.1096G>A (p.Val366Met) | single nucleotide variant | Epilepsy [RCV001363890] | Chr16:578811 [GRCh38] Chr16:628811 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.1593+1G>T | single nucleotide variant | Epilepsy [RCV001297427] | Chr16:582310 [GRCh38] Chr16:632310 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.1547G>A (p.Arg516His) | single nucleotide variant | Epilepsy [RCV001340206]|not provided [RCV004692591] | Chr16:582263 [GRCh38] Chr16:632263 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.945C>T (p.His315=) | single nucleotide variant | Epilepsy [RCV001413958] | Chr16:578381 [GRCh38] Chr16:628381 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.1578_1579del (p.Arg527fs) | deletion | Developmental and epileptic encephalopathy, 77 [RCV001290115] | Chr16:582294..582295 [GRCh38] Chr16:632294..632295 [GRCh37] Chr16:16p13.3 |
pathogenic |
NM_004204.5(PIGQ):c.951C>T (p.Ala317=) | single nucleotide variant | Epilepsy [RCV001422090]|not provided [RCV003394043] | Chr16:578387 [GRCh38] Chr16:628387 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.364G>C (p.Gly122Arg) | single nucleotide variant | Epilepsy [RCV001327438] | Chr16:574438 [GRCh38] Chr16:624438 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.1273C>T (p.Arg425Trp) | single nucleotide variant | Epilepsy [RCV001365418] | Chr16:579118 [GRCh38] Chr16:629118 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.928G>A (p.Val310Ile) | single nucleotide variant | Epilepsy [RCV001339484]|Inborn genetic diseases [RCV002546874] | Chr16:576240 [GRCh38] Chr16:626240 [GRCh37] Chr16:16p13.3 |
likely benign|uncertain significance |
NM_004204.5(PIGQ):c.1720A>G (p.Arg574Gly) | single nucleotide variant | Epilepsy [RCV001315359] | Chr16:583009 [GRCh38] Chr16:633009 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.1167G>A (p.Ser389=) | single nucleotide variant | Epilepsy [RCV001370469] | Chr16:578882 [GRCh38] Chr16:628882 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.1035C>T (p.Gly345=) | single nucleotide variant | Epilepsy [RCV001438303] | Chr16:578471 [GRCh38] Chr16:628471 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.1531+9del | deletion | Epilepsy [RCV001479200] | Chr16:580981 [GRCh38] Chr16:630981 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.603C>T (p.Leu201=) | single nucleotide variant | Epilepsy [RCV001476152] | Chr16:574677 [GRCh38] Chr16:624677 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.216G>A (p.Glu72=) | single nucleotide variant | Epilepsy [RCV001490949]|PIGQ-related disorder [RCV003980424] | Chr16:574290 [GRCh38] Chr16:624290 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.855C>T (p.Asp285=) | single nucleotide variant | Epilepsy [RCV001451619] | Chr16:576167 [GRCh38] Chr16:626167 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.993C>T (p.Pro331=) | single nucleotide variant | Epilepsy [RCV001496657]|PIGQ-related disorder [RCV003900713] | Chr16:578429 [GRCh38] Chr16:628429 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.40A>G (p.Thr14Ala) | single nucleotide variant | Developmental and epileptic encephalopathy, 77 [RCV001544397]|Epilepsy [RCV001511372]|not provided [RCV001685377]|not specified [RCV004594279] | Chr16:574114 [GRCh38] Chr16:624114 [GRCh37] Chr16:16p13.3 |
benign |
NM_004204.5(PIGQ):c.1461C>G (p.Leu487=) | single nucleotide variant | Developmental and epileptic encephalopathy, 77 [RCV001544405]|Epilepsy [RCV001511374]|not provided [RCV001692395] | Chr16:580902 [GRCh38] Chr16:630902 [GRCh37] Chr16:16p13.3 |
benign |
NM_004204.5(PIGQ):c.639C>T (p.Cys213=) | single nucleotide variant | Developmental and epileptic encephalopathy, 77 [RCV001544398]|Epilepsy [RCV001511373]|not provided [RCV001685378]|not specified [RCV004594280] | Chr16:574713 [GRCh38] Chr16:624713 [GRCh37] Chr16:16p13.3 |
benign |
NM_004204.5(PIGQ):c.1378C>T (p.Leu460=) | single nucleotide variant | Epilepsy [RCV001475502] | Chr16:580225 [GRCh38] Chr16:630225 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.1191C>T (p.Phe397=) | single nucleotide variant | Epilepsy [RCV001485205] | Chr16:578906 [GRCh38] Chr16:628906 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.1413C>G (p.Thr471=) | single nucleotide variant | Epilepsy [RCV001497292] | Chr16:580260 [GRCh38] Chr16:630260 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.741C>T (p.Cys247=) | single nucleotide variant | Epilepsy [RCV001393165] | Chr16:575890 [GRCh38] Chr16:625890 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.492C>T (p.Ala164=) | single nucleotide variant | Epilepsy [RCV001489729] | Chr16:574566 [GRCh38] Chr16:624566 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.708C>T (p.Pro236=) | single nucleotide variant | Epilepsy [RCV001474734] | Chr16:575857 [GRCh38] Chr16:625857 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.663G>A (p.Ser221=) | single nucleotide variant | Epilepsy [RCV001434974] | Chr16:574737 [GRCh38] Chr16:624737 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.979C>T (p.Leu327=) | single nucleotide variant | Epilepsy [RCV001491983] | Chr16:578415 [GRCh38] Chr16:628415 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.1224-10C>T | single nucleotide variant | Epilepsy [RCV001488518] | Chr16:579059 [GRCh38] Chr16:629059 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.480G>T (p.Gly160=) | single nucleotide variant | Epilepsy [RCV001498102] | Chr16:574554 [GRCh38] Chr16:624554 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.969G>A (p.Leu323=) | single nucleotide variant | Epilepsy [RCV001419801] | Chr16:578405 [GRCh38] Chr16:628405 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.1416+10G>A | single nucleotide variant | Epilepsy [RCV001431700] | Chr16:580273 [GRCh38] Chr16:630273 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.821+7G>T | single nucleotide variant | Epilepsy [RCV001440442] | Chr16:575977 [GRCh38] Chr16:625977 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.1179C>T (p.Ala393=) | single nucleotide variant | Epilepsy [RCV001445805]|not provided [RCV002264322] | Chr16:578894 [GRCh38] Chr16:628894 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.894G>A (p.Gly298=) | single nucleotide variant | Epilepsy [RCV001401899] | Chr16:576206 [GRCh38] Chr16:626206 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.102G>A (p.Ala34=) | single nucleotide variant | Epilepsy [RCV001486187] | Chr16:574176 [GRCh38] Chr16:624176 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.804C>T (p.Asn268=) | single nucleotide variant | Epilepsy [RCV001502481] | Chr16:575953 [GRCh38] Chr16:625953 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.402C>G (p.Arg134=) | single nucleotide variant | Epilepsy [RCV001465341] | Chr16:574476 [GRCh38] Chr16:624476 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.1532-17del | deletion | Developmental and epileptic encephalopathy, 77 [RCV001544035]|Epilepsy [RCV001511375]|not provided [RCV001655742]|not specified [RCV004594281] | Chr16:582231 [GRCh38] Chr16:632231 [GRCh37] Chr16:16p13.3 |
benign |
NM_004204.5(PIGQ):c.1532-15T>C | single nucleotide variant | Developmental and epileptic encephalopathy, 77 [RCV001544036]|Epilepsy [RCV001511376]|not provided [RCV001673072]|not specified [RCV004594282] | Chr16:582233 [GRCh38] Chr16:582233..582234 [GRCh38] Chr16:632233 [GRCh37] Chr16:632233..632234 [GRCh37] Chr16:16p13.3 |
benign |
NM_004204.5(PIGQ):c.1567G>A (p.Gly523Ser) | single nucleotide variant | Developmental and epileptic encephalopathy, 77 [RCV001544037]|Epilepsy [RCV001511377]|not provided [RCV001673073] | Chr16:582283 [GRCh38] Chr16:632283 [GRCh37] Chr16:16p13.3 |
benign |
NM_004204.5(PIGQ):c.1417-193G>A | single nucleotide variant | not provided [RCV001691660] | Chr16:580665 [GRCh38] Chr16:630665 [GRCh37] Chr16:16p13.3 |
benign |
NM_004204.5(PIGQ):c.*899C>T | single nucleotide variant | not provided [RCV001695907] | Chr16:583934 [GRCh38] Chr16:633934 [GRCh37] Chr16:16p13.3 |
benign |
NM_004204.5(PIGQ):c.690-169C>T | single nucleotide variant | not provided [RCV001616251] | Chr16:575670 [GRCh38] Chr16:625670 [GRCh37] Chr16:16p13.3 |
benign |
NM_004204.5(PIGQ):c.1716C>T (p.Pro572=) | single nucleotide variant | Epilepsy [RCV001498409] | Chr16:583005 [GRCh38] Chr16:633005 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.33C>T (p.Cys11=) | single nucleotide variant | Epilepsy [RCV001431109] | Chr16:574107 [GRCh38] Chr16:624107 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.64C>A (p.Arg22=) | single nucleotide variant | Epilepsy [RCV001486906] | Chr16:574138 [GRCh38] Chr16:624138 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.642G>T (p.Leu214=) | single nucleotide variant | Epilepsy [RCV001455525] | Chr16:574716 [GRCh38] Chr16:624716 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.1224-9G>A | single nucleotide variant | Epilepsy [RCV001465878] | Chr16:579060 [GRCh38] Chr16:629060 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.951C>G (p.Ala317=) | single nucleotide variant | Epilepsy [RCV001452026] | Chr16:578387 [GRCh38] Chr16:628387 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.1392C>T (p.Ala464=) | single nucleotide variant | Epilepsy [RCV001402063] | Chr16:580239 [GRCh38] Chr16:630239 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.129C>T (p.Ile43=) | single nucleotide variant | Epilepsy [RCV001440837] | Chr16:574203 [GRCh38] Chr16:624203 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.1635C>T (p.Arg545=) | single nucleotide variant | Epilepsy [RCV001441443] | Chr16:582924 [GRCh38] Chr16:632924 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.732C>T (p.Leu244=) | single nucleotide variant | Epilepsy [RCV001502679] | Chr16:575881 [GRCh38] Chr16:625881 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.190G>A (p.Gly64Ser) | single nucleotide variant | not provided [RCV001770580] | Chr16:574264 [GRCh38] Chr16:624264 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.241del (p.Leu81fs) | deletion | Developmental and epileptic encephalopathy, 77 [RCV001782630]|Epilepsy [RCV003107851] | Chr16:574314 [GRCh38] Chr16:624314 [GRCh37] Chr16:16p13.3 |
pathogenic|likely pathogenic |
NM_004204.5(PIGQ):c.682G>C (p.Ala228Pro) | single nucleotide variant | Epilepsy [RCV002032849]|not provided [RCV001767325] | Chr16:574756 [GRCh38] Chr16:624756 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.1345G>C (p.Gly449Arg) | single nucleotide variant | Developmental and epileptic encephalopathy, 77 [RCV001733884] | Chr16:580192 [GRCh38] Chr16:630192 [GRCh37] Chr16:16p13.3 |
likely pathogenic |
NM_004204.5(PIGQ):c.1036C>G (p.Arg346Gly) | single nucleotide variant | Epilepsy [RCV003645901]|not provided [RCV001771305] | Chr16:578472 [GRCh38] Chr16:628472 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.376G>A (p.Val126Ile) | single nucleotide variant | Inborn genetic diseases [RCV004040225]|not provided [RCV001758665] | Chr16:574450 [GRCh38] Chr16:624450 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.754C>T (p.His252Tyr) | single nucleotide variant | Epilepsy [RCV001874307] | Chr16:575903 [GRCh38] Chr16:625903 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.755A>C (p.His252Pro) | single nucleotide variant | Epilepsy [RCV001983088] | Chr16:575904 [GRCh38] Chr16:625904 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.819G>A (p.Met273Ile) | single nucleotide variant | Epilepsy [RCV001896536] | Chr16:575968 [GRCh38] Chr16:625968 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.626C>T (p.Ser209Leu) | single nucleotide variant | Epilepsy [RCV001913720]|Inborn genetic diseases [RCV002557627] | Chr16:574700 [GRCh38] Chr16:624700 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.902G>C (p.Arg301Pro) | single nucleotide variant | Epilepsy [RCV002025857] | Chr16:576214 [GRCh38] Chr16:626214 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.601C>T (p.Leu201Phe) | single nucleotide variant | Epilepsy [RCV002044149] | Chr16:574675 [GRCh38] Chr16:624675 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.91_106del (p.Val31fs) | deletion | Epilepsy [RCV001874706] | Chr16:574163..574178 [GRCh38] Chr16:624163..624178 [GRCh37] Chr16:16p13.3 |
pathogenic |
NM_004204.5(PIGQ):c.1088C>A (p.Ser363Tyr) | single nucleotide variant | Epilepsy [RCV001895251]|not provided [RCV002290787] | Chr16:578803 [GRCh38] Chr16:628803 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NC_000016.9:g.(?_624589)_(626254_?)del | deletion | Epilepsy [RCV001949702] | Chr16:624589..626254 [GRCh37] Chr16:16p13.3 |
pathogenic |
NM_004204.5(PIGQ):c.493G>A (p.Val165Ile) | single nucleotide variant | Epilepsy [RCV002009128] | Chr16:574567 [GRCh38] Chr16:624567 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.942+1G>C | single nucleotide variant | Epilepsy [RCV001949293] | Chr16:576255 [GRCh38] Chr16:626255 [GRCh37] Chr16:16p13.3 |
pathogenic |
NM_004204.5(PIGQ):c.335G>C (p.Arg112Pro) | single nucleotide variant | Epilepsy [RCV001896506] | Chr16:574409 [GRCh38] Chr16:624409 [GRCh37] Chr16:16p13.3 |
uncertain significance |
GRCh37/hg19 16p13.3(chr16:85880-754083) | copy number loss | not specified [RCV002052499] | Chr16:85880..754083 [GRCh37] Chr16:16p13.3 |
pathogenic |
NM_004204.5(PIGQ):c.1224-10C>G | single nucleotide variant | Epilepsy [RCV001863483] | Chr16:579059 [GRCh38] Chr16:629059 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.28T>G (p.Cys10Gly) | single nucleotide variant | Epilepsy [RCV001891581] | Chr16:574102 [GRCh38] Chr16:624102 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.481G>T (p.Gly161Cys) | single nucleotide variant | Epilepsy [RCV001894295]|not provided [RCV002243475] | Chr16:574555 [GRCh38] Chr16:624555 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.602T>C (p.Leu201Pro) | single nucleotide variant | Epilepsy [RCV002005121] | Chr16:574676 [GRCh38] Chr16:624676 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.1520A>G (p.Tyr507Cys) | single nucleotide variant | Epilepsy [RCV002040109] | Chr16:580961 [GRCh38] Chr16:630961 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.1146G>A (p.Thr382=) | single nucleotide variant | Epilepsy [RCV001912670] | Chr16:578861 [GRCh38] Chr16:628861 [GRCh37] Chr16:16p13.3 |
likely benign|uncertain significance |
NM_004204.5(PIGQ):c.1160T>G (p.Leu387Arg) | single nucleotide variant | Epilepsy [RCV001985330] | Chr16:578875 [GRCh38] Chr16:628875 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.514A>G (p.Ser172Gly) | single nucleotide variant | Epilepsy [RCV002042362]|Inborn genetic diseases [RCV004038889] | Chr16:574588 [GRCh38] Chr16:624588 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.1327_1335+2del | deletion | Epilepsy [RCV001966595] | Chr16:579172..579182 [GRCh38] Chr16:629172..629182 [GRCh37] Chr16:16p13.3 |
likely pathogenic |
NM_004204.5(PIGQ):c.578C>T (p.Ser193Leu) | single nucleotide variant | Epilepsy [RCV001965116] | Chr16:574652 [GRCh38] Chr16:624652 [GRCh37] Chr16:16p13.3 |
uncertain significance |
GRCh37/hg19 16p13.3(chr16:85880-1468828) | copy number loss | not specified [RCV002052500] | Chr16:85880..1468828 [GRCh37] Chr16:16p13.3 |
pathogenic |
NM_004204.5(PIGQ):c.662C>T (p.Ser221Leu) | single nucleotide variant | Epilepsy [RCV001947406]|Inborn genetic diseases [RCV002550400] | Chr16:574736 [GRCh38] Chr16:624736 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.1011C>G (p.Asn337Lys) | single nucleotide variant | Epilepsy [RCV001872747] | Chr16:578447 [GRCh38] Chr16:628447 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.12G>A (p.Lys4=) | single nucleotide variant | Epilepsy [RCV001912308] | Chr16:574086 [GRCh38] Chr16:624086 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.121A>T (p.Ile41Phe) | single nucleotide variant | Epilepsy [RCV002043401] | Chr16:574195 [GRCh38] Chr16:624195 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.42G>A (p.Thr14=) | single nucleotide variant | Epilepsy [RCV001945537] | Chr16:574116 [GRCh38] Chr16:624116 [GRCh37] Chr16:16p13.3 |
likely benign|uncertain significance |
NM_004204.5(PIGQ):c.847C>G (p.Leu283Val) | single nucleotide variant | Epilepsy [RCV001967502] | Chr16:576159 [GRCh38] Chr16:626159 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.1717del (p.Trp573fs) | deletion | Epilepsy [RCV001945618] | Chr16:583006 [GRCh38] Chr16:633006 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.559C>T (p.Arg187Trp) | single nucleotide variant | Epilepsy [RCV001887649] | Chr16:574633 [GRCh38] Chr16:624633 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.733_734del (p.Ser245fs) | microsatellite | Epilepsy [RCV002037933] | Chr16:575879..575880 [GRCh38] Chr16:625879..625880 [GRCh37] Chr16:16p13.3 |
pathogenic |
NM_004204.5(PIGQ):c.942+5G>A | single nucleotide variant | Epilepsy [RCV002034212] | Chr16:576259 [GRCh38] Chr16:626259 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.1306G>A (p.Val436Met) | single nucleotide variant | Epilepsy [RCV001919290] | Chr16:579151 [GRCh38] Chr16:629151 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.865G>C (p.Gly289Arg) | single nucleotide variant | Epilepsy [RCV001975475] | Chr16:576177 [GRCh38] Chr16:626177 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.333C>A (p.His111Gln) | single nucleotide variant | Epilepsy [RCV002049596]|Inborn genetic diseases [RCV002545743] | Chr16:574407 [GRCh38] Chr16:624407 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.1616G>A (p.Arg539His) | single nucleotide variant | Epilepsy [RCV001980098] | Chr16:582905 [GRCh38] Chr16:632905 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.842C>G (p.Ser281Cys) | single nucleotide variant | Epilepsy [RCV001941358] | Chr16:576154 [GRCh38] Chr16:626154 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.212A>G (p.Gln71Arg) | single nucleotide variant | Epilepsy [RCV002037203] | Chr16:574286 [GRCh38] Chr16:624286 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.1024C>T (p.Gln342Ter) | single nucleotide variant | Epilepsy [RCV001942790] | Chr16:578460 [GRCh38] Chr16:628460 [GRCh37] Chr16:16p13.3 |
pathogenic |
NM_004204.5(PIGQ):c.215A>T (p.Glu72Val) | single nucleotide variant | Epilepsy [RCV001944263] | Chr16:574289 [GRCh38] Chr16:624289 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.1669T>G (p.Trp557Gly) | single nucleotide variant | Epilepsy [RCV001888195] | Chr16:582958 [GRCh38] Chr16:632958 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.1579C>T (p.Arg527Cys) | single nucleotide variant | Epilepsy [RCV001888638] | Chr16:582295 [GRCh38] Chr16:632295 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.986G>A (p.Gly329Asp) | single nucleotide variant | Epilepsy [RCV001906535] | Chr16:578422 [GRCh38] Chr16:628422 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.1097T>C (p.Val366Ala) | single nucleotide variant | Epilepsy [RCV001958413] | Chr16:578812 [GRCh38] Chr16:628812 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.448C>T (p.Arg150Cys) | single nucleotide variant | Epilepsy [RCV001979428] | Chr16:574522 [GRCh38] Chr16:624522 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.1012C>A (p.Arg338Ser) | single nucleotide variant | Epilepsy [RCV001887021] | Chr16:578448 [GRCh38] Chr16:628448 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.177C>T (p.Gly59=) | single nucleotide variant | Epilepsy [RCV001887511] | Chr16:574251 [GRCh38] Chr16:624251 [GRCh37] Chr16:16p13.3 |
likely benign|uncertain significance |
NM_004204.5(PIGQ):c.233G>C (p.Gly78Ala) | single nucleotide variant | Epilepsy [RCV001962715] | Chr16:574307 [GRCh38] Chr16:624307 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.488C>G (p.Ala163Gly) | single nucleotide variant | Epilepsy [RCV001942533]|Inborn genetic diseases [RCV002550333] | Chr16:574562 [GRCh38] Chr16:624562 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.12G>T (p.Lys4Asn) | single nucleotide variant | Epilepsy [RCV001931998] | Chr16:574086 [GRCh38] Chr16:624086 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.340G>A (p.Ala114Thr) | single nucleotide variant | Epilepsy [RCV001938150] | Chr16:574414 [GRCh38] Chr16:624414 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.1244A>G (p.His415Arg) | single nucleotide variant | Epilepsy [RCV001936896] | Chr16:579089 [GRCh38] Chr16:629089 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.466A>G (p.Thr156Ala) | single nucleotide variant | Epilepsy [RCV001936933]|Inborn genetic diseases [RCV002562222] | Chr16:574540 [GRCh38] Chr16:624540 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.605C>A (p.Ala202Glu) | single nucleotide variant | Epilepsy [RCV001937579] | Chr16:574679 [GRCh38] Chr16:624679 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.1684del (p.Arg562fs) | deletion | Epilepsy [RCV002010546] | Chr16:582972 [GRCh38] Chr16:632972 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NC_000016.9:g.(?_256302)_(5971108_?)dup | duplication | Familial Mediterranean fever [RCV001877532]|Fanconi anemia [RCV001877533]|not provided [RCV001877531] | Chr16:256302..5971108 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.943-10G>A | single nucleotide variant | Epilepsy [RCV001992688]|PIGQ-related disorder [RCV003923386] | Chr16:578369 [GRCh38] Chr16:628369 [GRCh37] Chr16:16p13.3 |
likely benign|uncertain significance |
NM_004204.5(PIGQ):c.1335+17G>A | single nucleotide variant | Epilepsy [RCV001903426] | Chr16:579197 [GRCh38] Chr16:629197 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.1696C>T (p.Leu566Phe) | single nucleotide variant | Epilepsy [RCV001974641] | Chr16:582985 [GRCh38] Chr16:632985 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.901C>T (p.Arg301Cys) | single nucleotide variant | Epilepsy [RCV002012387]|not provided [RCV003389889] | Chr16:576213 [GRCh38] Chr16:626213 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.1529C>T (p.Ala510Val) | single nucleotide variant | Epilepsy [RCV001897632] | Chr16:580970 [GRCh38] Chr16:630970 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.64C>T (p.Arg22Trp) | single nucleotide variant | Epilepsy [RCV002016095]|Inborn genetic diseases [RCV004956133] | Chr16:574138 [GRCh38] Chr16:624138 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.90C>T (p.Ala30=) | single nucleotide variant | Epilepsy [RCV001925020] | Chr16:574164 [GRCh38] Chr16:624164 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.1531+5G>A | single nucleotide variant | Epilepsy [RCV001954282] | Chr16:580977 [GRCh38] Chr16:630977 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.293G>A (p.Arg98Gln) | single nucleotide variant | Epilepsy [RCV001883815] | Chr16:574367 [GRCh38] Chr16:624367 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.209G>A (p.Arg70Gln) | single nucleotide variant | Epilepsy [RCV001906935] | Chr16:574283 [GRCh38] Chr16:624283 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.502A>T (p.Thr168Ser) | single nucleotide variant | Epilepsy [RCV001953202] | Chr16:574576 [GRCh38] Chr16:624576 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.1616G>T (p.Arg539Leu) | single nucleotide variant | Epilepsy [RCV002018302] | Chr16:582905 [GRCh38] Chr16:632905 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.746A>G (p.Gln249Arg) | single nucleotide variant | Epilepsy [RCV001998292] | Chr16:575895 [GRCh38] Chr16:625895 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.1154T>C (p.Leu385Pro) | single nucleotide variant | Epilepsy [RCV001902052] | Chr16:578869 [GRCh38] Chr16:628869 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.629G>T (p.Gly210Val) | single nucleotide variant | Epilepsy [RCV001982321] | Chr16:574703 [GRCh38] Chr16:624703 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.1397A>G (p.Tyr466Cys) | single nucleotide variant | Epilepsy [RCV001876669] | Chr16:580244 [GRCh38] Chr16:630244 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.1069A>G (p.Ser357Gly) | single nucleotide variant | Epilepsy [RCV001934142] | Chr16:578505 [GRCh38] Chr16:628505 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.566G>A (p.Ser189Asn) | single nucleotide variant | Epilepsy [RCV001978950] | Chr16:574640 [GRCh38] Chr16:624640 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.234_254del (p.Arg79_Gly85del) | deletion | Epilepsy [RCV001958004] | Chr16:574296..574316 [GRCh38] Chr16:624296..624316 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.449del (p.Arg150fs) | deletion | Epilepsy [RCV001953542] | Chr16:574523 [GRCh38] Chr16:624523 [GRCh37] Chr16:16p13.3 |
pathogenic |
NM_004204.5(PIGQ):c.890A>C (p.His297Pro) | single nucleotide variant | Epilepsy [RCV001988954] | Chr16:576202 [GRCh38] Chr16:626202 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.1511G>A (p.Cys504Tyr) | single nucleotide variant | Epilepsy [RCV001932992] | Chr16:580952 [GRCh38] Chr16:630952 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.1069+17C>T | single nucleotide variant | Epilepsy [RCV001933151] | Chr16:578522 [GRCh38] Chr16:628522 [GRCh37] Chr16:16p13.3 |
likely benign|uncertain significance |
NM_004204.5(PIGQ):c.761T>C (p.Leu254Pro) | single nucleotide variant | Epilepsy [RCV001958195] | Chr16:575910 [GRCh38] Chr16:625910 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.271G>C (p.Glu91Gln) | single nucleotide variant | Developmental and epileptic encephalopathy, 77 [RCV004546684]|Epilepsy [RCV001898725] | Chr16:574345 [GRCh38] Chr16:624345 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.1564G>T (p.Ala522Ser) | single nucleotide variant | Epilepsy [RCV001869968] | Chr16:582280 [GRCh38] Chr16:632280 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.551del (p.Gly184fs) | deletion | Epilepsy [RCV001884226] | Chr16:574623 [GRCh38] Chr16:624623 [GRCh37] Chr16:16p13.3 |
pathogenic |
NM_004204.5(PIGQ):c.706C>T (p.Pro236Ser) | single nucleotide variant | Epilepsy [RCV001875663] | Chr16:575855 [GRCh38] Chr16:625855 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.161_174del (p.Gln54fs) | deletion | Epilepsy [RCV001994558] | Chr16:574235..574248 [GRCh38] Chr16:624235..624248 [GRCh37] Chr16:16p13.3 |
pathogenic |
NM_004204.5(PIGQ):c.690-3C>A | single nucleotide variant | Epilepsy [RCV002013011] | Chr16:575836 [GRCh38] Chr16:625836 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.833C>T (p.Thr278Met) | single nucleotide variant | Epilepsy [RCV002050359]|not provided [RCV004694165] | Chr16:576145 [GRCh38] Chr16:626145 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.76G>C (p.Glu26Gln) | single nucleotide variant | Epilepsy [RCV001907149] | Chr16:574150 [GRCh38] Chr16:624150 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.532A>C (p.Ser178Arg) | single nucleotide variant | Epilepsy [RCV001885995] | Chr16:574606 [GRCh38] Chr16:624606 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.1549G>A (p.Val517Ile) | single nucleotide variant | Epilepsy [RCV001885879] | Chr16:582265 [GRCh38] Chr16:632265 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.110A>G (p.His37Arg) | single nucleotide variant | Epilepsy [RCV001898960] | Chr16:574184 [GRCh38] Chr16:624184 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.325G>A (p.Ala109Thr) | single nucleotide variant | Developmental and epileptic encephalopathy, 77 [RCV004728881]|Epilepsy [RCV001877264]|Inborn genetic diseases [RCV004953227] | Chr16:574399 [GRCh38] Chr16:624399 [GRCh37] Chr16:16p13.3 |
likely benign|uncertain significance |
NM_004204.5(PIGQ):c.1106T>C (p.Ile369Thr) | single nucleotide variant | Epilepsy [RCV001922730] | Chr16:578821 [GRCh38] Chr16:628821 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.1728_1729del (p.Asp578fs) | microsatellite | Epilepsy [RCV001876623] | Chr16:583013..583014 [GRCh38] Chr16:633013..633014 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.1392C>G (p.Ala464=) | single nucleotide variant | Epilepsy [RCV002014279] | Chr16:580239 [GRCh38] Chr16:630239 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.352C>T (p.Pro118Ser) | single nucleotide variant | Epilepsy [RCV002027338] | Chr16:574426 [GRCh38] Chr16:624426 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.554C>G (p.Pro185Arg) | single nucleotide variant | Epilepsy [RCV001992988] | Chr16:574628 [GRCh38] Chr16:624628 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.539G>A (p.Arg180His) | single nucleotide variant | Epilepsy [RCV001935123] | Chr16:574613 [GRCh38] Chr16:624613 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.1435G>A (p.Ala479Thr) | single nucleotide variant | Epilepsy [RCV001989312] | Chr16:580876 [GRCh38] Chr16:630876 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.707C>T (p.Pro236Leu) | single nucleotide variant | Epilepsy [RCV001880463]|Inborn genetic diseases [RCV004039590] | Chr16:575856 [GRCh38] Chr16:625856 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.1173T>G (p.Ile391Met) | single nucleotide variant | Epilepsy [RCV001867571]|Inborn genetic diseases [RCV002550421] | Chr16:578888 [GRCh38] Chr16:628888 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.38C>T (p.Ser13Leu) | single nucleotide variant | Epilepsy [RCV001931846] | Chr16:574112 [GRCh38] Chr16:624112 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.643_644delinsAC (p.Leu215Thr) | indel | Epilepsy [RCV001901415] | Chr16:574717..574718 [GRCh38] Chr16:624717..624718 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.52_70dup (p.Val24fs) | duplication | Epilepsy [RCV001935593] | Chr16:574122..574123 [GRCh38] Chr16:624122..624123 [GRCh37] Chr16:16p13.3 |
pathogenic |
NM_004204.5(PIGQ):c.1594-19G>A | single nucleotide variant | Epilepsy [RCV002109840] | Chr16:582864 [GRCh38] Chr16:632864 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.943-14C>T | single nucleotide variant | Epilepsy [RCV002185598] | Chr16:578365 [GRCh38] Chr16:628365 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.1080C>T (p.His360=) | single nucleotide variant | Epilepsy [RCV002073657] | Chr16:578795 [GRCh38] Chr16:628795 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.822-16C>T | single nucleotide variant | Epilepsy [RCV002074581] | Chr16:576118 [GRCh38] Chr16:626118 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.1069+18G>A | single nucleotide variant | Epilepsy [RCV002124461] | Chr16:578523 [GRCh38] Chr16:628523 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.1593+17C>G | single nucleotide variant | Epilepsy [RCV002206378] | Chr16:582326 [GRCh38] Chr16:632326 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.1257A>G (p.Ser419=) | single nucleotide variant | Epilepsy [RCV002209697] | Chr16:579102 [GRCh38] Chr16:629102 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.738G>A (p.Thr246=) | single nucleotide variant | Epilepsy [RCV002129386] | Chr16:575887 [GRCh38] Chr16:625887 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.354C>T (p.Pro118=) | single nucleotide variant | Epilepsy [RCV002107997] | Chr16:574428 [GRCh38] Chr16:624428 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.1473C>T (p.Ile491=) | single nucleotide variant | Epilepsy [RCV002148948] | Chr16:580914 [GRCh38] Chr16:630914 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.880T>C (p.Ser294Pro) | single nucleotide variant | Developmental and epileptic encephalopathy, 77 [RCV002208763] | Chr16:576192 [GRCh38] Chr16:626192 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.957G>A (p.Glu319=) | single nucleotide variant | Epilepsy [RCV002189218] | Chr16:578393 [GRCh38] Chr16:628393 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.1336-19T>C | single nucleotide variant | Epilepsy [RCV002109296] | Chr16:580164 [GRCh38] Chr16:630164 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.1245T>C (p.His415=) | single nucleotide variant | Epilepsy [RCV002125515] | Chr16:579090 [GRCh38] Chr16:629090 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.1366C>T (p.Leu456=) | single nucleotide variant | Epilepsy [RCV002167825] | Chr16:580213 [GRCh38] Chr16:630213 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.689+11C>T | single nucleotide variant | Epilepsy [RCV002106196] | Chr16:574774 [GRCh38] Chr16:624774 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.1070-11C>A | single nucleotide variant | Epilepsy [RCV002105244] | Chr16:578774 [GRCh38] Chr16:628774 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.1417-12C>T | single nucleotide variant | Epilepsy [RCV002196264] | Chr16:580846 [GRCh38] Chr16:630846 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.1224-20G>C | single nucleotide variant | Epilepsy [RCV002091451] | Chr16:579049 [GRCh38] Chr16:629049 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.249C>T (p.Ser83=) | single nucleotide variant | Epilepsy [RCV002096910] | Chr16:574323 [GRCh38] Chr16:624323 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.1437C>G (p.Ala479=) | single nucleotide variant | Epilepsy [RCV002093919] | Chr16:580878 [GRCh38] Chr16:630878 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.*515C>G | single nucleotide variant | PIGQ-related disorder [RCV003933695]|not provided [RCV002211320] | Chr16:583550 [GRCh38] Chr16:633550 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.1593G>A (p.Gln531=) | single nucleotide variant | Epilepsy [RCV001944959] | Chr16:582309 [GRCh38] Chr16:632309 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.1317T>C (p.Cys439=) | single nucleotide variant | Epilepsy [RCV002172923] | Chr16:579162 [GRCh38] Chr16:629162 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.862C>T (p.Leu288=) | single nucleotide variant | Epilepsy [RCV002213186] | Chr16:576174 [GRCh38] Chr16:626174 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.891C>T (p.His297=) | single nucleotide variant | Epilepsy [RCV002107634] | Chr16:576203 [GRCh38] Chr16:626203 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.309G>A (p.Thr103=) | single nucleotide variant | Epilepsy [RCV002093493] | Chr16:574383 [GRCh38] Chr16:624383 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.555C>T (p.Pro185=) | single nucleotide variant | Epilepsy [RCV002094559] | Chr16:574629 [GRCh38] Chr16:624629 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.1305C>T (p.Arg435=) | single nucleotide variant | Epilepsy [RCV002152917] | Chr16:579150 [GRCh38] Chr16:629150 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.408G>A (p.Val136=) | single nucleotide variant | Epilepsy [RCV002173086] | Chr16:574482 [GRCh38] Chr16:624482 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.1224-13C>T | single nucleotide variant | Epilepsy [RCV002192892] | Chr16:579056 [GRCh38] Chr16:629056 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.1359C>T (p.Phe453=) | single nucleotide variant | Epilepsy [RCV002094725] | Chr16:580206 [GRCh38] Chr16:630206 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.606G>A (p.Ala202=) | single nucleotide variant | Epilepsy [RCV002114698] | Chr16:574680 [GRCh38] Chr16:624680 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.1070-14C>T | single nucleotide variant | Epilepsy [RCV002187740] | Chr16:578771 [GRCh38] Chr16:628771 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.1281G>A (p.Lys427=) | single nucleotide variant | Epilepsy [RCV002110216] | Chr16:579126 [GRCh38] Chr16:629126 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.1070-13C>T | single nucleotide variant | Epilepsy [RCV002153131] | Chr16:578772 [GRCh38] Chr16:628772 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.689+16C>T | single nucleotide variant | Epilepsy [RCV002150760] | Chr16:574779 [GRCh38] Chr16:624779 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.1223+11G>T | single nucleotide variant | Epilepsy [RCV002171536] | Chr16:578949 [GRCh38] Chr16:628949 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.1335+16C>T | single nucleotide variant | Epilepsy [RCV002185587] | Chr16:579196 [GRCh38] Chr16:629196 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.444C>T (p.Pro148=) | single nucleotide variant | Epilepsy [RCV002113281] | Chr16:574518 [GRCh38] Chr16:624518 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.943-14_943-13del | deletion | Epilepsy [RCV002114392] | Chr16:578365..578366 [GRCh38] Chr16:628365..628366 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.1069+15G>A | single nucleotide variant | Epilepsy [RCV002138908] | Chr16:578520 [GRCh38] Chr16:628520 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.640C>T (p.Leu214=) | single nucleotide variant | Epilepsy [RCV002178923] | Chr16:574714 [GRCh38] Chr16:624714 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.1593+7C>T | single nucleotide variant | Epilepsy [RCV002138575] | Chr16:582316 [GRCh38] Chr16:632316 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.1560C>T (p.His520=) | single nucleotide variant | Epilepsy [RCV002082989] | Chr16:582276 [GRCh38] Chr16:632276 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.684C>T (p.Ala228=) | single nucleotide variant | Epilepsy [RCV002144387] | Chr16:574758 [GRCh38] Chr16:624758 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.1336-11C>G | single nucleotide variant | Epilepsy [RCV002216735]|not provided [RCV004715591] | Chr16:580172 [GRCh38] Chr16:630172 [GRCh37] Chr16:16p13.3 |
benign |
NM_004204.5(PIGQ):c.525C>T (p.Leu175=) | single nucleotide variant | Epilepsy [RCV002098783] | Chr16:574599 [GRCh38] Chr16:624599 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.689+12G>A | single nucleotide variant | Epilepsy [RCV002164154] | Chr16:574775 [GRCh38] Chr16:624775 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.1336-12C>G | single nucleotide variant | Epilepsy [RCV002099175] | Chr16:580171 [GRCh38] Chr16:630171 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.1594-20C>T | single nucleotide variant | Epilepsy [RCV002099489] | Chr16:582863 [GRCh38] Chr16:632863 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.219C>G (p.Pro73=) | single nucleotide variant | Epilepsy [RCV002103064] | Chr16:574293 [GRCh38] Chr16:624293 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.658C>T (p.Leu220=) | single nucleotide variant | Epilepsy [RCV002119650] | Chr16:574732 [GRCh38] Chr16:624732 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.1416+8G>A | single nucleotide variant | Epilepsy [RCV002158090] | Chr16:580271 [GRCh38] Chr16:630271 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.1531+14A>G | single nucleotide variant | Epilepsy [RCV002119483] | Chr16:580986 [GRCh38] Chr16:630986 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.1070-15A>G | single nucleotide variant | Epilepsy [RCV002203036] | Chr16:578770 [GRCh38] Chr16:628770 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.1149G>C (p.Val383=) | single nucleotide variant | Epilepsy [RCV002197901] | Chr16:578864 [GRCh38] Chr16:628864 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.1070-9C>T | single nucleotide variant | Epilepsy [RCV002180819] | Chr16:578776 [GRCh38] Chr16:628776 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.21C>T (p.Phe7=) | single nucleotide variant | Epilepsy [RCV002120030] | Chr16:574095 [GRCh38] Chr16:624095 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.1668C>T (p.Ser556=) | single nucleotide variant | Epilepsy [RCV002162176] | Chr16:582957 [GRCh38] Chr16:632957 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.1434C>T (p.Val478=) | single nucleotide variant | Epilepsy [RCV002156693] | Chr16:580875 [GRCh38] Chr16:630875 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.690-18C>A | single nucleotide variant | Epilepsy [RCV002098542] | Chr16:575821 [GRCh38] Chr16:625821 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.1611C>T (p.Tyr537=) | single nucleotide variant | Epilepsy [RCV002143833] | Chr16:582900 [GRCh38] Chr16:632900 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.612G>A (p.Leu204=) | single nucleotide variant | Epilepsy [RCV002120413] | Chr16:574686 [GRCh38] Chr16:624686 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.1012C>G (p.Arg338Gly) | single nucleotide variant | Developmental and epileptic encephalopathy, 77 [RCV002204534]|Epilepsy [RCV003101219] | Chr16:578448 [GRCh38] Chr16:628448 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.1167G>T (p.Ser389=) | single nucleotide variant | Epilepsy [RCV002099258] | Chr16:578882 [GRCh38] Chr16:628882 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.1531+11C>T | single nucleotide variant | Epilepsy [RCV002155535]|not provided [RCV004715612] | Chr16:580983 [GRCh38] Chr16:630983 [GRCh37] Chr16:16p13.3 |
benign |
NM_004204.5(PIGQ):c.1101G>A (p.Glu367=) | single nucleotide variant | Epilepsy [RCV002101554] | Chr16:578816 [GRCh38] Chr16:628816 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.1393C>T (p.Leu465=) | single nucleotide variant | Epilepsy [RCV002184692] | Chr16:580240 [GRCh38] Chr16:630240 [GRCh37] Chr16:16p13.3 |
likely benign |
NC_000016.9:g.(?_256302)_(4852572_?)dup | duplication | Epilepsy [RCV003113403]|Idiopathic generalized epilepsy [RCV003109446]|Saldino-Mainzer syndrome [RCV003113404] | Chr16:256302..4852572 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NC_000016.9:g.(?_256302)_(1843653_?)del | deletion | Idiopathic generalized epilepsy [RCV003109815] | Chr16:256302..1843653 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NC_000016.9:g.(?_289853)_(626274_?)dup | duplication | Epilepsy [RCV003113400] | Chr16:289853..626274 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NC_000016.9:g.(?_622268)_(632290_?)del | deletion | Epilepsy [RCV003113401] | Chr16:622268..632290 [GRCh37] Chr16:16p13.3 |
pathogenic |
NC_000016.9:g.(?_256302)_(633035_?)del | deletion | Epilepsy [RCV003113402] | Chr16:256302..633035 [GRCh37] Chr16:16p13.3 |
pathogenic |
NC_000016.9:g.(?_256302)_(1657267_?)del | deletion | Saldino-Mainzer syndrome [RCV003116765]|not provided [RCV003116766] | Chr16:256302..1657267 [GRCh37] Chr16:16p13.3 |
pathogenic|no classifications from unflagged records |
NC_000016.9:g.(?_256302)_(1918176_?)del | deletion | not provided [RCV003119703] | Chr16:256302..1918176 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.1429G>A (p.Val477Met) | single nucleotide variant | Epilepsy [RCV003120082] | Chr16:580870 [GRCh38] Chr16:630870 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.734C>T (p.Ser245Phe) | single nucleotide variant | Epilepsy [RCV002296903] | Chr16:575883 [GRCh38] Chr16:625883 [GRCh37] Chr16:16p13.3 |
uncertain significance |
GRCh37/hg19 16p13.3(chr16:111043-6627459)x3 | copy number gain | See cases [RCV002292215] | Chr16:111043..6627459 [GRCh37] Chr16:16p13.3 |
pathogenic |
NM_004204.5(PIGQ):c.1184T>A (p.Leu395His) | single nucleotide variant | not provided [RCV002290938] | Chr16:578899 [GRCh38] Chr16:628899 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.517G>C (p.Glu173Gln) | single nucleotide variant | Epilepsy [RCV002297542] | Chr16:574591 [GRCh38] Chr16:624591 [GRCh37] Chr16:16p13.3 |
uncertain significance |
GRCh37/hg19 16p13.3(chr16:85881-1350186)x1 | copy number loss | not provided [RCV002474576] | Chr16:85881..1350186 [GRCh37] Chr16:16p13.3 |
pathogenic |
NM_004204.5(PIGQ):c.227G>T (p.Ser76Ile) | single nucleotide variant | Epilepsy [RCV002304581] | Chr16:574301 [GRCh38] Chr16:624301 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.1139G>A (p.Gly380Asp) | single nucleotide variant | Epilepsy [RCV002295768] | Chr16:578854 [GRCh38] Chr16:628854 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.1127C>T (p.Ser376Leu) | single nucleotide variant | Epilepsy [RCV002615807] | Chr16:578842 [GRCh38] Chr16:628842 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.1509C>T (p.Leu503=) | single nucleotide variant | Epilepsy [RCV002616430] | Chr16:580950 [GRCh38] Chr16:630950 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.734C>G (p.Ser245Cys) | single nucleotide variant | Epilepsy [RCV003032874] | Chr16:575883 [GRCh38] Chr16:625883 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.1453C>T (p.His485Tyr) | single nucleotide variant | Epilepsy [RCV002731136] | Chr16:580894 [GRCh38] Chr16:630894 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.241C>T (p.Leu81=) | single nucleotide variant | Epilepsy [RCV002615430] | Chr16:574315 [GRCh38] Chr16:624315 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.1736A>G (p.Lys579Arg) | single nucleotide variant | Epilepsy [RCV002843205] | Chr16:583025 [GRCh38] Chr16:633025 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.1213T>C (p.Tyr405His) | single nucleotide variant | Epilepsy [RCV002975570] | Chr16:578928 [GRCh38] Chr16:628928 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.1639C>A (p.Pro547Thr) | single nucleotide variant | Epilepsy [RCV002843702] | Chr16:582928 [GRCh38] Chr16:632928 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.*351C>T | single nucleotide variant | Inborn genetic diseases [RCV002997556] | Chr16:583386 [GRCh38] Chr16:633386 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.924C>T (p.Ala308=) | single nucleotide variant | Epilepsy [RCV002819534] | Chr16:576236 [GRCh38] Chr16:626236 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.90C>G (p.Ala30=) | single nucleotide variant | Epilepsy [RCV002819800] | Chr16:574164 [GRCh38] Chr16:624164 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.1336-4A>T | single nucleotide variant | Epilepsy [RCV003075071] | Chr16:580179 [GRCh38] Chr16:630179 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.1594-7C>T | single nucleotide variant | Epilepsy [RCV002751453] | Chr16:582876 [GRCh38] Chr16:632876 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.272_273delinsTT (p.Glu91Val) | indel | Epilepsy [RCV003012030] | Chr16:574346..574347 [GRCh38] Chr16:624346..624347 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.1685G>T (p.Arg562Leu) | single nucleotide variant | Epilepsy [RCV003016032] | Chr16:582974 [GRCh38] Chr16:632974 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.1684C>T (p.Arg562Cys) | single nucleotide variant | Epilepsy [RCV003075285] | Chr16:582973 [GRCh38] Chr16:632973 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.470C>G (p.Ala157Gly) | single nucleotide variant | Inborn genetic diseases [RCV002727813] | Chr16:574544 [GRCh38] Chr16:624544 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.386T>C (p.Ile129Thr) | single nucleotide variant | Inborn genetic diseases [RCV002879520] | Chr16:574460 [GRCh38] Chr16:624460 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.689+14G>A | single nucleotide variant | Epilepsy [RCV003074445] | Chr16:574777 [GRCh38] Chr16:624777 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.606G>T (p.Ala202=) | single nucleotide variant | Epilepsy [RCV002755279] | Chr16:574680 [GRCh38] Chr16:624680 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.889C>T (p.His297Tyr) | single nucleotide variant | Inborn genetic diseases [RCV002793449] | Chr16:576201 [GRCh38] Chr16:626201 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.1571G>C (p.Arg524Thr) | single nucleotide variant | Epilepsy [RCV003032536] | Chr16:582287 [GRCh38] Chr16:632287 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.689+18G>A | single nucleotide variant | Epilepsy [RCV002776535] | Chr16:574781 [GRCh38] Chr16:624781 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.292C>T (p.Arg98Trp) | single nucleotide variant | Inborn genetic diseases [RCV002981059] | Chr16:574366 [GRCh38] Chr16:624366 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.1487T>A (p.Leu496Gln) | single nucleotide variant | Epilepsy [RCV002740300] | Chr16:580928 [GRCh38] Chr16:630928 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.1683C>T (p.Cys561=) | single nucleotide variant | Epilepsy [RCV002886158] | Chr16:582972 [GRCh38] Chr16:632972 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.1223+3G>A | single nucleotide variant | Epilepsy [RCV002785506] | Chr16:578941 [GRCh38] Chr16:628941 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.100G>C (p.Ala34Pro) | single nucleotide variant | Epilepsy [RCV002927581] | Chr16:574174 [GRCh38] Chr16:624174 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.616A>T (p.Arg206Trp) | single nucleotide variant | Epilepsy [RCV002999401]|Inborn genetic diseases [RCV003377828] | Chr16:574690 [GRCh38] Chr16:624690 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.1511G>T (p.Cys504Phe) | single nucleotide variant | Inborn genetic diseases [RCV002950305] | Chr16:580952 [GRCh38] Chr16:630952 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.156G>A (p.Val52=) | single nucleotide variant | Epilepsy [RCV002705266] | Chr16:574230 [GRCh38] Chr16:624230 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.1072T>C (p.Tyr358His) | single nucleotide variant | Epilepsy [RCV002914401] | Chr16:578787 [GRCh38] Chr16:628787 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.909del (p.His304fs) | deletion | Epilepsy [RCV003055493] | Chr16:576219 [GRCh38] Chr16:626219 [GRCh37] Chr16:16p13.3 |
pathogenic |
NM_004204.5(PIGQ):c.690-17_690-13del | deletion | Epilepsy [RCV003081478] | Chr16:575818..575822 [GRCh38] Chr16:625818..625822 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.1007T>G (p.Met336Arg) | single nucleotide variant | Epilepsy [RCV003080277] | Chr16:578443 [GRCh38] Chr16:628443 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.822-8C>A | single nucleotide variant | Epilepsy [RCV002571749] | Chr16:576126 [GRCh38] Chr16:626126 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.865G>A (p.Gly289Ser) | single nucleotide variant | Epilepsy [RCV002761604]|Inborn genetic diseases [RCV003167727] | Chr16:576177 [GRCh38] Chr16:626177 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.1260G>T (p.Leu420=) | single nucleotide variant | Epilepsy [RCV002847123] | Chr16:579105 [GRCh38] Chr16:629105 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.821+11G>T | single nucleotide variant | Epilepsy [RCV002796225] | Chr16:575981 [GRCh38] Chr16:625981 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.474C>T (p.Ser158=) | single nucleotide variant | Epilepsy [RCV002886246] | Chr16:574548 [GRCh38] Chr16:624548 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.418C>T (p.Gln140Ter) | single nucleotide variant | Epilepsy [RCV002948386] | Chr16:574492 [GRCh38] Chr16:624492 [GRCh37] Chr16:16p13.3 |
pathogenic |
NM_004204.5(PIGQ):c.1690C>G (p.Leu564Val) | single nucleotide variant | Epilepsy [RCV003019953] | Chr16:582979 [GRCh38] Chr16:632979 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.1388C>T (p.Thr463Ile) | single nucleotide variant | Epilepsy [RCV003053653] | Chr16:580235 [GRCh38] Chr16:630235 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.520G>A (p.Val174Met) | single nucleotide variant | Epilepsy [RCV002637810] | Chr16:574594 [GRCh38] Chr16:624594 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.1547G>C (p.Arg516Pro) | single nucleotide variant | Epilepsy [RCV002592094] | Chr16:582263 [GRCh38] Chr16:632263 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.283C>T (p.Arg95Trp) | single nucleotide variant | Epilepsy [RCV002885555] | Chr16:574357 [GRCh38] Chr16:624357 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.227G>A (p.Ser76Asn) | single nucleotide variant | Epilepsy [RCV003080037] | Chr16:574301 [GRCh38] Chr16:624301 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.952G>A (p.Glu318Lys) | single nucleotide variant | Epilepsy [RCV003002272] | Chr16:578388 [GRCh38] Chr16:628388 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.710T>C (p.Leu237Pro) | single nucleotide variant | Epilepsy [RCV003037849] | Chr16:575859 [GRCh38] Chr16:625859 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.1269G>C (p.Leu423=) | single nucleotide variant | Epilepsy [RCV002927125] | Chr16:579114 [GRCh38] Chr16:629114 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.1015G>A (p.Ala339Thr) | single nucleotide variant | Epilepsy [RCV002706411] | Chr16:578451 [GRCh38] Chr16:628451 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.1239G>A (p.Lys413=) | single nucleotide variant | Epilepsy [RCV003037202] | Chr16:579084 [GRCh38] Chr16:629084 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.386TCT[1] (p.Phe130del) | microsatellite | Epilepsy [RCV002761456] | Chr16:574460..574462 [GRCh38] Chr16:624460..624462 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.511C>T (p.Arg171Cys) | single nucleotide variant | Epilepsy [RCV002619360] | Chr16:574585 [GRCh38] Chr16:624585 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.610C>T (p.Leu204=) | single nucleotide variant | Epilepsy [RCV002885650] | Chr16:574684 [GRCh38] Chr16:624684 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.1069+13C>G | single nucleotide variant | Epilepsy [RCV002885032] | Chr16:578518 [GRCh38] Chr16:628518 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.1623G>A (p.Val541=) | single nucleotide variant | Epilepsy [RCV003077961] | Chr16:582912 [GRCh38] Chr16:632912 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.1326C>T (p.Asp442=) | single nucleotide variant | Epilepsy [RCV003085163] | Chr16:579171 [GRCh38] Chr16:629171 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.791G>A (p.Arg264Gln) | single nucleotide variant | Epilepsy [RCV002624005]|Inborn genetic diseases [RCV004961133] | Chr16:575940 [GRCh38] Chr16:625940 [GRCh37] Chr16:16p13.3 |
likely benign|uncertain significance |
NM_004204.5(PIGQ):c.86G>A (p.Ser29Asn) | single nucleotide variant | Epilepsy [RCV002745352] | Chr16:574160 [GRCh38] Chr16:624160 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.68G>A (p.Trp23Ter) | single nucleotide variant | Epilepsy [RCV002791062] | Chr16:574142 [GRCh38] Chr16:624142 [GRCh37] Chr16:16p13.3 |
pathogenic |
NM_004204.5(PIGQ):c.1407G>A (p.Val469=) | single nucleotide variant | Epilepsy [RCV002642209] | Chr16:580254 [GRCh38] Chr16:630254 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.822-20G>A | single nucleotide variant | Epilepsy [RCV003005464] | Chr16:576114 [GRCh38] Chr16:626114 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.271G>A (p.Glu91Lys) | single nucleotide variant | Epilepsy [RCV002644395] | Chr16:574345 [GRCh38] Chr16:624345 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.852G>A (p.Leu284=) | single nucleotide variant | Epilepsy [RCV002829059] | Chr16:576164 [GRCh38] Chr16:626164 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.210G>A (p.Arg70=) | single nucleotide variant | Epilepsy [RCV002958317] | Chr16:574284 [GRCh38] Chr16:624284 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.1380G>T (p.Leu460=) | single nucleotide variant | Epilepsy [RCV002932639] | Chr16:580227 [GRCh38] Chr16:630227 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.627G>A (p.Ser209=) | single nucleotide variant | Epilepsy [RCV003082008] | Chr16:574701 [GRCh38] Chr16:624701 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.625T>G (p.Ser209Ala) | single nucleotide variant | Epilepsy [RCV002624198] | Chr16:574699 [GRCh38] Chr16:624699 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.499G>C (p.Asp167His) | single nucleotide variant | Epilepsy [RCV003042020] | Chr16:574573 [GRCh38] Chr16:624573 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.700C>T (p.Leu234Phe) | single nucleotide variant | Epilepsy [RCV003081997] | Chr16:575849 [GRCh38] Chr16:625849 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.1529C>A (p.Ala510Glu) | single nucleotide variant | Epilepsy [RCV003083158]|Inborn genetic diseases [RCV004654136] | Chr16:580970 [GRCh38] Chr16:630970 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.585C>T (p.Gly195=) | single nucleotide variant | Epilepsy [RCV002917984] | Chr16:574659 [GRCh38] Chr16:624659 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.773C>T (p.Thr258Met) | single nucleotide variant | Inborn genetic diseases [RCV002916733] | Chr16:575922 [GRCh38] Chr16:625922 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.1566C>T (p.Ala522=) | single nucleotide variant | Epilepsy [RCV002595317] | Chr16:582282 [GRCh38] Chr16:632282 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.1594-13C>T | single nucleotide variant | Epilepsy [RCV003005807] | Chr16:582870 [GRCh38] Chr16:632870 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.124C>G (p.Pro42Ala) | single nucleotide variant | Epilepsy [RCV003056333] | Chr16:574198 [GRCh38] Chr16:624198 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.942C>T (p.Asp314=) | single nucleotide variant | Epilepsy [RCV002625010] | Chr16:576254 [GRCh38] Chr16:626254 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.1536C>T (p.Gly512=) | single nucleotide variant | Epilepsy [RCV003007183] | Chr16:582252 [GRCh38] Chr16:632252 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.1636C>T (p.Leu546Phe) | single nucleotide variant | Epilepsy [RCV002596297] | Chr16:582925 [GRCh38] Chr16:632925 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.1512C>T (p.Cys504=) | single nucleotide variant | Epilepsy [RCV003025754] | Chr16:580953 [GRCh38] Chr16:630953 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.751C>A (p.Arg251=) | single nucleotide variant | Epilepsy [RCV002594229] | Chr16:575900 [GRCh38] Chr16:625900 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.284G>A (p.Arg95Gln) | single nucleotide variant | Epilepsy [RCV002574568] | Chr16:574358 [GRCh38] Chr16:624358 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.892G>T (p.Gly298Trp) | single nucleotide variant | Epilepsy [RCV002766001] | Chr16:576204 [GRCh38] Chr16:626204 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.1593+12T>G | single nucleotide variant | Epilepsy [RCV003084881] | Chr16:582321 [GRCh38] Chr16:632321 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.1417C>G (p.Leu473Val) | single nucleotide variant | Epilepsy [RCV002624773] | Chr16:580858 [GRCh38] Chr16:630858 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.*379G>A | single nucleotide variant | Inborn genetic diseases [RCV002986032]|not provided [RCV003542465] | Chr16:583414 [GRCh38] Chr16:633414 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.804C>A (p.Asn268Lys) | single nucleotide variant | Epilepsy [RCV003084331]|Inborn genetic diseases [RCV003089934] | Chr16:575953 [GRCh38] Chr16:625953 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.849G>A (p.Leu283=) | single nucleotide variant | Epilepsy [RCV002790780] | Chr16:576161 [GRCh38] Chr16:626161 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.1594-8C>T | single nucleotide variant | Epilepsy [RCV002800638] | Chr16:582875 [GRCh38] Chr16:632875 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.1178C>T (p.Ala393Val) | single nucleotide variant | Epilepsy [RCV002953911] | Chr16:578893 [GRCh38] Chr16:628893 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.1026G>A (p.Gln342=) | single nucleotide variant | Epilepsy [RCV003055859] | Chr16:578462 [GRCh38] Chr16:628462 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.1324G>A (p.Asp442Asn) | single nucleotide variant | Epilepsy [RCV003049153] | Chr16:579169 [GRCh38] Chr16:629169 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.921C>T (p.Asp307=) | single nucleotide variant | Epilepsy [RCV002900209] | Chr16:576233 [GRCh38] Chr16:626233 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.1621G>A (p.Val541Met) | single nucleotide variant | Epilepsy [RCV002627803] | Chr16:582910 [GRCh38] Chr16:632910 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.1002C>A (p.Leu334=) | single nucleotide variant | Epilepsy [RCV003061572] | Chr16:578438 [GRCh38] Chr16:628438 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.741C>G (p.Cys247Trp) | single nucleotide variant | Epilepsy [RCV002834943] | Chr16:575890 [GRCh38] Chr16:625890 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.1290C>T (p.Asn430=) | single nucleotide variant | Epilepsy [RCV002628913] | Chr16:579135 [GRCh38] Chr16:629135 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.*508C>T | single nucleotide variant | Inborn genetic diseases [RCV002668645] | Chr16:583543 [GRCh38] Chr16:633543 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.1521C>G (p.Tyr507Ter) | single nucleotide variant | Epilepsy [RCV003046658] | Chr16:580962 [GRCh38] Chr16:630962 [GRCh37] Chr16:16p13.3 |
pathogenic |
NM_004204.5(PIGQ):c.642G>A (p.Leu214=) | single nucleotide variant | Epilepsy [RCV003086367] | Chr16:574716 [GRCh38] Chr16:624716 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.1532-5T>C | single nucleotide variant | Epilepsy [RCV003045780] | Chr16:582243 [GRCh38] Chr16:632243 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.399G>C (p.Gln133His) | single nucleotide variant | Epilepsy [RCV003046076] | Chr16:574473 [GRCh38] Chr16:624473 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.352C>G (p.Pro118Ala) | single nucleotide variant | Inborn genetic diseases [RCV002809643] | Chr16:574426 [GRCh38] Chr16:624426 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.*133C>T | single nucleotide variant | Inborn genetic diseases [RCV002747886] | Chr16:583168 [GRCh38] Chr16:633168 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.1723C>T (p.Gln575Ter) | single nucleotide variant | Epilepsy [RCV002933556] | Chr16:583012 [GRCh38] Chr16:633012 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.1495C>T (p.Leu499=) | single nucleotide variant | Epilepsy [RCV002579103] | Chr16:580936 [GRCh38] Chr16:630936 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.1406T>C (p.Val469Ala) | single nucleotide variant | Epilepsy [RCV003087724] | Chr16:580253 [GRCh38] Chr16:630253 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.435C>T (p.Thr145=) | single nucleotide variant | Epilepsy [RCV002599749] | Chr16:574509 [GRCh38] Chr16:624509 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.1224-20G>A | single nucleotide variant | Epilepsy [RCV002647916] | Chr16:579049 [GRCh38] Chr16:629049 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.1210G>T (p.Val404Phe) | single nucleotide variant | Epilepsy [RCV003047138] | Chr16:578925 [GRCh38] Chr16:628925 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.687C>T (p.Cys229=) | single nucleotide variant | Epilepsy [RCV003009772] | Chr16:574761 [GRCh38] Chr16:624761 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.*117C>G | single nucleotide variant | Inborn genetic diseases [RCV002747972]|not provided [RCV004572817] | Chr16:583152 [GRCh38] Chr16:633152 [GRCh37] Chr16:16p13.3 |
likely benign|uncertain significance |
NM_004204.5(PIGQ):c.572G>A (p.Trp191Ter) | single nucleotide variant | Inborn genetic diseases [RCV002855222] | Chr16:574646 [GRCh38] Chr16:624646 [GRCh37] Chr16:16p13.3 |
pathogenic |
NM_004204.5(PIGQ):c.1224-16G>A | single nucleotide variant | Epilepsy [RCV003087376] | Chr16:579053 [GRCh38] Chr16:629053 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.303C>T (p.Gly101=) | single nucleotide variant | Epilepsy [RCV003061435] | Chr16:574377 [GRCh38] Chr16:624377 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.745C>A (p.Gln249Lys) | single nucleotide variant | Inborn genetic diseases [RCV002648418] | Chr16:575894 [GRCh38] Chr16:625894 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.1457T>G (p.Leu486Arg) | single nucleotide variant | Epilepsy [RCV003065687] | Chr16:580898 [GRCh38] Chr16:630898 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.125C>T (p.Pro42Leu) | single nucleotide variant | Epilepsy [RCV003091132] | Chr16:574199 [GRCh38] Chr16:624199 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.*303C>T | single nucleotide variant | Inborn genetic diseases [RCV002677566] | Chr16:583338 [GRCh38] Chr16:633338 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.1A>C (p.Met1Leu) | single nucleotide variant | Epilepsy [RCV003092915] | Chr16:574075 [GRCh38] Chr16:624075 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.817A>G (p.Met273Val) | single nucleotide variant | Epilepsy [RCV003066810] | Chr16:575966 [GRCh38] Chr16:625966 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.*487C>A | single nucleotide variant | Inborn genetic diseases [RCV002657240]|not provided [RCV003389923] | Chr16:583522 [GRCh38] Chr16:633522 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.882C>T (p.Ser294=) | single nucleotide variant | Epilepsy [RCV002603350] | Chr16:576194 [GRCh38] Chr16:626194 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.1133G>C (p.Cys378Ser) | single nucleotide variant | Epilepsy [RCV002654341] | Chr16:578848 [GRCh38] Chr16:628848 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.688C>G (p.Arg230Gly) | single nucleotide variant | Epilepsy [RCV003052594] | Chr16:574762 [GRCh38] Chr16:624762 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.40_41inv (p.Thr14Val) | inversion | Epilepsy [RCV002610103] | Chr16:574114..574115 [GRCh38] Chr16:624114..624115 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.101C>T (p.Ala34Val) | single nucleotide variant | Epilepsy [RCV003093376] | Chr16:574175 [GRCh38] Chr16:624175 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.254dup (p.Ala86fs) | duplication | Epilepsy [RCV002943760] | Chr16:574325..574326 [GRCh38] Chr16:624325..624326 [GRCh37] Chr16:16p13.3 |
pathogenic |
NM_004204.5(PIGQ):c.637T>C (p.Cys213Arg) | single nucleotide variant | Epilepsy [RCV002585330] | Chr16:574711 [GRCh38] Chr16:624711 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.234C>T (p.Gly78=) | single nucleotide variant | Epilepsy [RCV002604773] | Chr16:574308 [GRCh38] Chr16:624308 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.1075_1085del (p.Ile359fs) | deletion | Developmental and epileptic encephalopathy, 77 [RCV003131962] | Chr16:578790..578800 [GRCh38] Chr16:628790..628800 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.1556G>C (p.Arg519Pro) | single nucleotide variant | Developmental and epileptic encephalopathy, 77 [RCV003131963] | Chr16:582272 [GRCh38] Chr16:632272 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.1673del (p.Gly558fs) | deletion | Developmental and epileptic encephalopathy, 77 [RCV003142677] | Chr16:582959 [GRCh38] Chr16:632959 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.1479C>T (p.Ser493=) | single nucleotide variant | Epilepsy [RCV003530318]|not provided [RCV003395118] | Chr16:580920 [GRCh38] Chr16:630920 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.*203C>T | single nucleotide variant | PIGQ-related disorder [RCV003929065]|not provided [RCV003395120] | Chr16:583238 [GRCh38] Chr16:633238 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.*339C>T | single nucleotide variant | not provided [RCV003395121] | Chr16:583374 [GRCh38] Chr16:633374 [GRCh37] Chr16:16p13.3 |
likely benign|uncertain significance |
NM_004204.5(PIGQ):c.645G>T (p.Leu215=) | single nucleotide variant | Epilepsy [RCV003874124] | Chr16:574719 [GRCh38] Chr16:624719 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.689+13G>A | single nucleotide variant | Epilepsy [RCV003873585] | Chr16:574776 [GRCh38] Chr16:624776 [GRCh37] Chr16:16p13.3 |
likely benign |
GRCh37/hg19 16p13.3(chr16:85881-1657611)x1 | copy number loss | not provided [RCV003483253] | Chr16:85881..1657611 [GRCh37] Chr16:16p13.3 |
pathogenic |
NM_004204.5(PIGQ):c.436G>A (p.Val146Ile) | single nucleotide variant | not provided [RCV003390589] | Chr16:574510 [GRCh38] Chr16:624510 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.*104G>A | single nucleotide variant | not provided [RCV003395119] | Chr16:583139 [GRCh38] Chr16:633139 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.1714C>T (p.Pro572Ser) | single nucleotide variant | not provided [RCV003390590] | Chr16:583003 [GRCh38] Chr16:633003 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.*533C>T | single nucleotide variant | not provided [RCV003390591] | Chr16:583568 [GRCh38] Chr16:633568 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.821+58A>G | single nucleotide variant | not provided [RCV003395117] | Chr16:576028 [GRCh38] Chr16:626028 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.*340G>A | single nucleotide variant | not provided [RCV003395122] | Chr16:583375 [GRCh38] Chr16:633375 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.1215T>G (p.Tyr405Ter) | single nucleotide variant | PIGQ-related disorder [RCV003412383] | Chr16:578930 [GRCh38] Chr16:628930 [GRCh37] Chr16:16p13.3 |
likely pathogenic |
NM_004204.5(PIGQ):c.1425C>T (p.Leu475=) | single nucleotide variant | Epilepsy [RCV003530576] | Chr16:580866 [GRCh38] Chr16:630866 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.1417-12C>A | single nucleotide variant | Epilepsy [RCV003530438] | Chr16:580846 [GRCh38] Chr16:630846 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.1062G>A (p.Leu354=) | single nucleotide variant | Epilepsy [RCV003530857] | Chr16:578498 [GRCh38] Chr16:628498 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.1176C>T (p.Ile392=) | single nucleotide variant | Epilepsy [RCV003530978] | Chr16:578891 [GRCh38] Chr16:628891 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.195C>A (p.Thr65=) | single nucleotide variant | Epilepsy [RCV003530866] | Chr16:574269 [GRCh38] Chr16:624269 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.689+8T>C | single nucleotide variant | Epilepsy [RCV003530731] | Chr16:574771 [GRCh38] Chr16:624771 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.943-15C>T | single nucleotide variant | Epilepsy [RCV003530490] | Chr16:578364 [GRCh38] Chr16:628364 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.1182C>T (p.Leu394=) | single nucleotide variant | Epilepsy [RCV003530771] | Chr16:578897 [GRCh38] Chr16:628897 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.48C>T (p.Ser16=) | single nucleotide variant | Epilepsy [RCV003530670] | Chr16:574122 [GRCh38] Chr16:624122 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.753G>C (p.Arg251=) | single nucleotide variant | Epilepsy [RCV003530677] | Chr16:575902 [GRCh38] Chr16:625902 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.321C>T (p.Cys107=) | single nucleotide variant | Epilepsy [RCV003530678] | Chr16:574395 [GRCh38] Chr16:624395 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.1185C>T (p.Leu395=) | single nucleotide variant | Epilepsy [RCV003530692] | Chr16:578900 [GRCh38] Chr16:628900 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.1434C>G (p.Val478=) | single nucleotide variant | Epilepsy [RCV003646152] | Chr16:580875 [GRCh38] Chr16:630875 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.1069+22del | deletion | Epilepsy [RCV003646785] | Chr16:578523 [GRCh38] Chr16:628523 [GRCh37] Chr16:16p13.3 |
benign |
NM_004204.5(PIGQ):c.477G>T (p.Thr159=) | single nucleotide variant | Epilepsy [RCV003881082] | Chr16:574551 [GRCh38] Chr16:624551 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.444C>G (p.Pro148=) | single nucleotide variant | Epilepsy [RCV003646367] | Chr16:574518 [GRCh38] Chr16:624518 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.1071C>G (p.Ser357Arg) | single nucleotide variant | Epilepsy [RCV003646629] | Chr16:578786 [GRCh38] Chr16:628786 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.834G>A (p.Thr278=) | single nucleotide variant | Epilepsy [RCV003647220] | Chr16:576146 [GRCh38] Chr16:626146 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.906C>T (p.Ile302=) | single nucleotide variant | Epilepsy [RCV003647239] | Chr16:576218 [GRCh38] Chr16:626218 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.1680G>A (p.Leu560=) | single nucleotide variant | Epilepsy [RCV003646547] | Chr16:582969 [GRCh38] Chr16:632969 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.1713C>T (p.Tyr571=) | single nucleotide variant | Epilepsy [RCV003646469] | Chr16:583002 [GRCh38] Chr16:633002 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.1491C>T (p.Tyr497=) | single nucleotide variant | Epilepsy [RCV003647136] | Chr16:580932 [GRCh38] Chr16:630932 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.1557G>A (p.Arg519=) | single nucleotide variant | Epilepsy [RCV003647175] | Chr16:582273 [GRCh38] Chr16:632273 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.1335+12G>A | single nucleotide variant | Epilepsy [RCV003530398] | Chr16:579192 [GRCh38] Chr16:629192 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.780C>T (p.Ile260=) | single nucleotide variant | Epilepsy [RCV003646167] | Chr16:575929 [GRCh38] Chr16:625929 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.1069+16G>C | single nucleotide variant | Epilepsy [RCV003646896] | Chr16:578521 [GRCh38] Chr16:628521 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.1223+7G>T | single nucleotide variant | Epilepsy [RCV003646932] | Chr16:578945 [GRCh38] Chr16:628945 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.286C>T (p.Leu96=) | single nucleotide variant | Epilepsy [RCV003646981] | Chr16:574360 [GRCh38] Chr16:624360 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.967C>T (p.Leu323=) | single nucleotide variant | Epilepsy [RCV003646378] | Chr16:578403 [GRCh38] Chr16:628403 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.690-20T>C | single nucleotide variant | Epilepsy [RCV003646973] | Chr16:575819 [GRCh38] Chr16:625819 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.1521C>T (p.Tyr507=) | single nucleotide variant | Epilepsy [RCV003530352] | Chr16:580962 [GRCh38] Chr16:630962 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.223G>T (p.Glu75Ter) | single nucleotide variant | Epilepsy [RCV003646427] | Chr16:574297 [GRCh38] Chr16:624297 [GRCh37] Chr16:16p13.3 |
pathogenic |
NM_004204.5(PIGQ):c.1692G>A (p.Leu564=) | single nucleotide variant | Epilepsy [RCV003647005]|Inborn genetic diseases [RCV004953465] | Chr16:582981 [GRCh38] Chr16:632981 [GRCh37] Chr16:16p13.3 |
likely benign|uncertain significance |
NM_004204.5(PIGQ):c.573G>A (p.Trp191Ter) | single nucleotide variant | Epilepsy [RCV003647022] | Chr16:574647 [GRCh38] Chr16:624647 [GRCh37] Chr16:16p13.3 |
pathogenic |
NM_004204.5(PIGQ):c.1674C>A (p.Gly558=) | single nucleotide variant | Epilepsy [RCV003646357] | Chr16:582963 [GRCh38] Chr16:632963 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.774G>A (p.Thr258=) | single nucleotide variant | Epilepsy [RCV003647112] | Chr16:575923 [GRCh38] Chr16:625923 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.690-12A>G | single nucleotide variant | Epilepsy [RCV003646523] | Chr16:575827 [GRCh38] Chr16:625827 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.1069+16G>T | single nucleotide variant | Epilepsy [RCV003646577] | Chr16:578521 [GRCh38] Chr16:628521 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.1029G>C (p.Val343=) | single nucleotide variant | Epilepsy [RCV003646630] | Chr16:578465 [GRCh38] Chr16:628465 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.822-11C>T | single nucleotide variant | Epilepsy [RCV003646856] | Chr16:576123 [GRCh38] Chr16:626123 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.159G>A (p.Arg53=) | single nucleotide variant | Epilepsy [RCV003646163] | Chr16:574233 [GRCh38] Chr16:624233 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.1531+12G>A | single nucleotide variant | Epilepsy [RCV003646907] | Chr16:580984 [GRCh38] Chr16:630984 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.774G>T (p.Thr258=) | single nucleotide variant | Epilepsy [RCV003646282] | Chr16:575923 [GRCh38] Chr16:625923 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.105C>T (p.Val35=) | single nucleotide variant | Epilepsy [RCV003646213] | Chr16:574179 [GRCh38] Chr16:624179 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.1336-20G>A | single nucleotide variant | Epilepsy [RCV003879718] | Chr16:580163 [GRCh38] Chr16:630163 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.39G>A (p.Ser13=) | single nucleotide variant | Epilepsy [RCV003531014] | Chr16:574113 [GRCh38] Chr16:624113 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.1284G>A (p.Lys428=) | single nucleotide variant | Epilepsy [RCV003531176] | Chr16:579129 [GRCh38] Chr16:629129 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.1185C>A (p.Leu395=) | single nucleotide variant | Epilepsy [RCV003531087] | Chr16:578900 [GRCh38] Chr16:628900 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.60G>A (p.Val20=) | single nucleotide variant | Epilepsy [RCV003531168] | Chr16:574134 [GRCh38] Chr16:624134 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.1059C>T (p.His353=) | single nucleotide variant | Epilepsy [RCV003531282] | Chr16:578495 [GRCh38] Chr16:628495 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.1531+1G>A | single nucleotide variant | Epilepsy [RCV003531030] | Chr16:580973 [GRCh38] Chr16:630973 [GRCh37] Chr16:16p13.3 |
likely pathogenic |
NM_004204.5(PIGQ):c.275C>A (p.Pro92His) | single nucleotide variant | Epilepsy [RCV003816122] | Chr16:574349 [GRCh38] Chr16:624349 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.1593+14T>A | single nucleotide variant | Epilepsy [RCV003531249] | Chr16:582323 [GRCh38] Chr16:632323 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.927C>T (p.Leu309=) | single nucleotide variant | Epilepsy [RCV003850680] | Chr16:576239 [GRCh38] Chr16:626239 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.1249C>T (p.Leu417=) | single nucleotide variant | Epilepsy [RCV003817546] | Chr16:579094 [GRCh38] Chr16:629094 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.396C>T (p.Asp132=) | single nucleotide variant | Epilepsy [RCV003531359] | Chr16:574470 [GRCh38] Chr16:624470 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.758G>A (p.Arg253Gln) | single nucleotide variant | Epilepsy [RCV003815175] | Chr16:575907 [GRCh38] Chr16:625907 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.220G>T (p.Glu74Ter) | single nucleotide variant | Epilepsy [RCV003838695] | Chr16:574294 [GRCh38] Chr16:624294 [GRCh37] Chr16:16p13.3 |
pathogenic |
NM_004204.5(PIGQ):c.1335+18T>G | single nucleotide variant | Epilepsy [RCV003531210] | Chr16:579198 [GRCh38] Chr16:629198 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.1638C>T (p.Leu546=) | single nucleotide variant | Epilepsy [RCV003531315] | Chr16:582927 [GRCh38] Chr16:632927 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.255dup (p.Ala86fs) | duplication | Epilepsy [RCV003867035] | Chr16:574328..574329 [GRCh38] Chr16:624328..624329 [GRCh37] Chr16:16p13.3 |
pathogenic |
NM_004204.5(PIGQ):c.1740G>A (p.Gln580=) | single nucleotide variant | Epilepsy [RCV003841210] | Chr16:583029 [GRCh38] Chr16:633029 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.420G>A (p.Gln140=) | single nucleotide variant | not provided [RCV003887330] | Chr16:574494 [GRCh38] Chr16:624494 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.1412C>T (p.Thr471Ile) | single nucleotide variant | not provided [RCV003885038] | Chr16:580259 [GRCh38] Chr16:630259 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.*81C>T | single nucleotide variant | not provided [RCV003885153] | Chr16:583116 [GRCh38] Chr16:633116 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.1134_1143del (p.Ala377_Cys378insTer) | deletion | PIGQ-related disorder [RCV003896979] | Chr16:578843..578852 [GRCh38] Chr16:628843..628852 [GRCh37] Chr16:16p13.3 |
likely pathogenic |
NM_004204.5(PIGQ):c.*95T>C | single nucleotide variant | PIGQ-related disorder [RCV003966939] | Chr16:583130 [GRCh38] Chr16:633130 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.1229A>G (p.Tyr410Cys) | single nucleotide variant | Inborn genetic diseases [RCV004503738] | Chr16:579074 [GRCh38] Chr16:629074 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.983T>C (p.Met328Thr) | single nucleotide variant | Inborn genetic diseases [RCV004503739] | Chr16:578419 [GRCh38] Chr16:628419 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NC_000016.9:g.(?_256302)_(1557737_?)del | deletion | not provided [RCV004582850] | Chr16:256302..1557737 [GRCh37] Chr16:16p13.3 |
pathogenic |
NM_004204.5(PIGQ):c.821+74C>T | single nucleotide variant | not provided [RCV004575147] | Chr16:576044 [GRCh38] Chr16:626044 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NC_000016.9:g.(?_624075)_(633035_?)del | deletion | Epilepsy [RCV004581459] | Chr16:624075..633035 [GRCh37] Chr16:16p13.3 |
pathogenic |
NC_000016.9:g.(?_339420)_(3767509_?)dup | duplication | Epilepsy [RCV004581460]|Idiopathic generalized epilepsy [RCV004581461] | Chr16:339420..3767509 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NC_000016.9:g.(?_628765)_(633035_?)dup | duplication | Epilepsy [RCV004581462] | Chr16:628765..633035 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NC_000016.9:g.(?_396128)_(1204056_?)dup | duplication | Idiopathic generalized epilepsy [RCV004581577] | Chr16:396128..1204056 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.1721G>A (p.Arg574Lys) | single nucleotide variant | Inborn genetic diseases [RCV004657175] | Chr16:583010 [GRCh38] Chr16:633010 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.519G>T (p.Glu173Asp) | single nucleotide variant | Inborn genetic diseases [RCV004648198] | Chr16:574593 [GRCh38] Chr16:624593 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.1389A>G (p.Thr463=) | single nucleotide variant | not provided [RCV004809505] | Chr16:580236 [GRCh38] Chr16:630236 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.942+3G>C | single nucleotide variant | not provided [RCV004781024] | Chr16:576257 [GRCh38] Chr16:626257 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.*383G>A | single nucleotide variant | PIGQ-related disorder [RCV004728128] | Chr16:583418 [GRCh38] Chr16:633418 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.*364A>T | single nucleotide variant | not provided [RCV004722478] | Chr16:583399 [GRCh38] Chr16:633399 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.*473C>T | single nucleotide variant | not provided [RCV004722676] | Chr16:583508 [GRCh38] Chr16:633508 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.235C>T (p.Arg79Cys) | single nucleotide variant | Inborn genetic diseases [RCV004959778] | Chr16:574309 [GRCh38] Chr16:624309 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_004204.5(PIGQ):c.1330G>A (p.Asp444Asn) | single nucleotide variant | Inborn genetic diseases [RCV004959779] | Chr16:579175 [GRCh38] Chr16:629175 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.1665C>T (p.His555=) | single nucleotide variant | Inborn genetic diseases [RCV004959781] | Chr16:582954 [GRCh38] Chr16:632954 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_004204.5(PIGQ):c.958C>A (p.Leu320Ile) | single nucleotide variant | Inborn genetic diseases [RCV004959780] | Chr16:578394 [GRCh38] Chr16:628394 [GRCh37] Chr16:16p13.3 |
uncertain significance |
GRCh37/hg19 16p13.3(chr16:513767-5555136)x3 | copy number gain | not provided [RCV004819313] | Chr16:513767..5555136 [GRCh37] Chr16:16p13.3 |
pathogenic |
NM_004204.5(PIGQ):c.*69C>T | single nucleotide variant | not provided [RCV005001651] | Chr16:583104 [GRCh38] Chr16:633104 [GRCh37] Chr16:16p13.3 |
uncertain significance |
GRCh37/hg19 16p13.3-13.13(chr16:85881-12268399)x3 | copy number gain | not provided [RCV004819312] | Chr16:85881..12268399 [GRCh37] Chr16:16p13.3-13.13 |
pathogenic |
The detailed report is available here: | ![]() | Full Report | ![]() | CSV | ![]() | TAB | ![]() | Printer |
miRNA Target Status data imported from miRGate (http://mirgate.bioinfo.cnio.es/). For more information about miRGate, see PMID:25858286 or access the full paper here. |
The following QTLs overlap with this region. | ![]() | Full Report | ![]() | CSV | ![]() | TAB | ![]() | Printer | ![]() | Gviewer |
D11S3316 |
|
adipose tissue
|
alimentary part of gastrointestinal system
|
appendage
|
circulatory system
|
ectoderm
|
endocrine system
|
endoderm
|
entire extraembryonic component
|
exocrine system
|
hemolymphoid system
|
hepatobiliary system
|
integumental system
|
mesenchyme
|
mesoderm
|
musculoskeletal system
|
nervous system
|
pharyngeal arch
|
renal system
|
reproductive system
|
respiratory system
|
sensory system
|
visual system
|
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1204 | 2439 | 2788 | 2253 | 4974 | 1726 | 2351 | 6 | 624 | 1950 | 465 | 2270 | 7305 | 6471 | 53 | 3734 | 1 | 852 | 1744 | 1617 | 175 | 1 |
RefSeq Transcripts | NG_034206 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles |
NM_004204 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
NM_148920 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
GenBank Nucleotide | AB003723 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles |
AE006464 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
AF030177 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
AK055163 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
AK092073 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
AK300297 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
AK314361 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
BC006377 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
BC010094 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
CH471112 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
CP068262 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
DA206420 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
R45240 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
Z98883 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles |
Ensembl Acc Id: | ENST00000026218 ⟹ ENSP00000026218 | ||||||||
Type: | CODING | ||||||||
Position: |
|
Ensembl Acc Id: | ENST00000293874 ⟹ ENSP00000293874 | ||||||||
Type: | CODING | ||||||||
Position: |
|
Ensembl Acc Id: | ENST00000321878 ⟹ ENSP00000326674 | ||||||||
Type: | CODING | ||||||||
Position: |
|
Ensembl Acc Id: | ENST00000409527 ⟹ ENSP00000386760 | ||||||||
Type: | CODING | ||||||||
Position: |
|
Ensembl Acc Id: | ENST00000420990 ⟹ ENSP00000409341 | ||||||||
Type: | CODING | ||||||||
Position: |
|
Ensembl Acc Id: | ENST00000422307 ⟹ ENSP00000413753 | ||||||||
Type: | CODING | ||||||||
Position: |
|
Ensembl Acc Id: | ENST00000439574 ⟹ ENSP00000387820 | ||||||||
Type: | CODING | ||||||||
Position: |
|
Ensembl Acc Id: | ENST00000443147 ⟹ ENSP00000410434 | ||||||||
Type: | CODING | ||||||||
Position: |
|
Ensembl Acc Id: | ENST00000470411 ⟹ ENSP00000439650 | ||||||||
Type: | CODING | ||||||||
Position: |
|
Ensembl Acc Id: | ENST00000476438 | ||||||||
Type: | CODING | ||||||||
Position: |
|
Ensembl Acc Id: | ENST00000480424 | ||||||||
Type: | CODING | ||||||||
Position: |
|
Ensembl Acc Id: | ENST00000537901 | ||||||||
Type: | CODING | ||||||||
Position: |
|
Ensembl Acc Id: | ENST00000540241 ⟹ ENSP00000439374 | ||||||||
Type: | CODING | ||||||||
Position: |
|
Ensembl Acc Id: | ENST00000540548 | ||||||||
Type: | CODING | ||||||||
Position: |
|
Ensembl Acc Id: | ENST00000544860 | ||||||||
Type: | CODING | ||||||||
Position: |
|
Ensembl Acc Id: | ENST00000634341 | ||||||||
Type: | CODING | ||||||||
Position: |
|
Ensembl Acc Id: | ENST00000635205 ⟹ ENSP00000489216 | ||||||||
Type: | CODING | ||||||||
Position: |
|
Ensembl Acc Id: | ENST00000635909 ⟹ ENSP00000490267 | ||||||||
Type: | CODING | ||||||||
Position: |
|
Ensembl Acc Id: | ENST00000635935 | ||||||||
Type: | CODING | ||||||||
Position: |
|
Ensembl Acc Id: | ENST00000636005 ⟹ ENSP00000490498 | ||||||||
Type: | CODING | ||||||||
Position: |
|
Ensembl Acc Id: | ENST00000636657 ⟹ ENSP00000490087 | ||||||||
Type: | CODING | ||||||||
Position: |
|
Ensembl Acc Id: | ENST00000637468 ⟹ ENSP00000490672 | ||||||||
Type: | CODING | ||||||||
Position: |
|
Ensembl Acc Id: | ENST00000637701 | ||||||||
Type: | CODING | ||||||||
Position: |
|
Ensembl Acc Id: | ENST00000638143 ⟹ ENSP00000490695 | ||||||||
Type: | CODING | ||||||||
Position: |
|
Ensembl Acc Id: | ENST00000638152 | ||||||||
Type: | CODING | ||||||||
Position: |
|
RefSeq Acc Id: | NM_004204 ⟹ NP_004195 | ||||||||||||||||||||||||||||||||
RefSeq Status: | REVIEWED | ||||||||||||||||||||||||||||||||
Type: | CODING | ||||||||||||||||||||||||||||||||
Position: |
|
||||||||||||||||||||||||||||||||
Sequence: |
RefSeq Acc Id: | NM_148920 ⟹ NP_683721 | ||||||||||||||||||||||||||||||||
RefSeq Status: | REVIEWED | ||||||||||||||||||||||||||||||||
Type: | CODING | ||||||||||||||||||||||||||||||||
Position: |
|
||||||||||||||||||||||||||||||||
Sequence: |
Protein RefSeqs | NP_004195 | (Get FASTA) | NCBI Sequence Viewer |
NP_683721 | (Get FASTA) | NCBI Sequence Viewer | |
GenBank Protein | AAC32661 | (Get FASTA) | NCBI Sequence Viewer |
AAH06377 | (Get FASTA) | NCBI Sequence Viewer | |
AAK61235 | (Get FASTA) | NCBI Sequence Viewer | |
BAA24948 | (Get FASTA) | NCBI Sequence Viewer | |
BAG36993 | (Get FASTA) | NCBI Sequence Viewer | |
BAG52479 | (Get FASTA) | NCBI Sequence Viewer | |
BAG62051 | (Get FASTA) | NCBI Sequence Viewer | |
EAW85795 | (Get FASTA) | NCBI Sequence Viewer | |
EAW85796 | (Get FASTA) | NCBI Sequence Viewer | |
EAW85797 | (Get FASTA) | NCBI Sequence Viewer | |
EAW85798 | (Get FASTA) | NCBI Sequence Viewer | |
EAW85799 | (Get FASTA) | NCBI Sequence Viewer | |
EAW85800 | (Get FASTA) | NCBI Sequence Viewer | |
Ensembl Protein | ENSP00000026218 | ||
ENSP00000026218.5 | |||
ENSP00000293874 | |||
ENSP00000326674 | |||
ENSP00000326674.6 | |||
ENSP00000386760.2 | |||
ENSP00000387820.1 | |||
ENSP00000409341.2 | |||
ENSP00000410434.1 | |||
ENSP00000413753.2 | |||
ENSP00000439374.1 | |||
ENSP00000439650.1 | |||
ENSP00000489216.1 | |||
ENSP00000490087.1 | |||
ENSP00000490267.1 | |||
ENSP00000490498.1 | |||
ENSP00000490672.1 | |||
ENSP00000490695.1 | |||
GenBank Protein | Q9BRB3 | (Get FASTA) | NCBI Sequence Viewer |
RefSeq Acc Id: | NP_683721 ⟸ NM_148920 |
- Peptide Label: | isoform 1 |
- UniProtKB: | Q96S22 (UniProtKB/Swiss-Prot), Q96G00 (UniProtKB/Swiss-Prot), O14927 (UniProtKB/Swiss-Prot), D3DU52 (UniProtKB/Swiss-Prot), A2IDE1 (UniProtKB/Swiss-Prot), Q9UJH4 (UniProtKB/Swiss-Prot), Q9BRB3 (UniProtKB/Swiss-Prot) |
- Sequence: |
RefSeq Acc Id: | NP_004195 ⟸ NM_004204 |
- Peptide Label: | isoform 2 |
- UniProtKB: | B2RAU6 (UniProtKB/TrEMBL) |
- Sequence: |
Ensembl Acc Id: | ENSP00000489216 ⟸ ENST00000635205 |
Ensembl Acc Id: | ENSP00000387820 ⟸ ENST00000439574 |
Ensembl Acc Id: | ENSP00000490267 ⟸ ENST00000635909 |
Ensembl Acc Id: | ENSP00000490498 ⟸ ENST00000636005 |
Ensembl Acc Id: | ENSP00000490087 ⟸ ENST00000636657 |
Ensembl Acc Id: | ENSP00000293874 ⟸ ENST00000293874 |
Ensembl Acc Id: | ENSP00000490672 ⟸ ENST00000637468 |
Ensembl Acc Id: | ENSP00000490695 ⟸ ENST00000638143 |
Ensembl Acc Id: | ENSP00000326674 ⟸ ENST00000321878 |
Ensembl Acc Id: | ENSP00000410434 ⟸ ENST00000443147 |
Ensembl Acc Id: | ENSP00000439650 ⟸ ENST00000470411 |
Ensembl Acc Id: | ENSP00000026218 ⟸ ENST00000026218 |
Ensembl Acc Id: | ENSP00000386760 ⟸ ENST00000409527 |
Ensembl Acc Id: | ENSP00000409341 ⟸ ENST00000420990 |
Ensembl Acc Id: | ENSP00000439374 ⟸ ENST00000540241 |
Ensembl Acc Id: | ENSP00000413753 ⟸ ENST00000422307 |
Name | Modeler | Protein Id | AA Range | Protein Structure |
AF-Q9BRB3-F1-model_v2 | AlphaFold | Q9BRB3 | 1-760 | view protein structure |
RGD ID: | 6793369 | ||||||||
Promoter ID: | HG_KWN:22619 | ||||||||
Type: | CpG-Island | ||||||||
SO ACC ID: | SO:0000170 | ||||||||
Source: | MPROMDB | ||||||||
Tissues & Cell Lines: | K562, Lymphoblastoid, NB4 | ||||||||
Transcripts: | OTTHUMT00000333922, UC010BQW.1 | ||||||||
Position: |
|
RGD ID: | 6792989 | ||||||||
Promoter ID: | HG_KWN:22620 | ||||||||
Type: | CpG-Island | ||||||||
SO ACC ID: | SO:0000170 | ||||||||
Source: | MPROMDB | ||||||||
Tissues & Cell Lines: | CD4+TCell, CD4+TCell_12Hour, HeLa_S3, K562, Lymphoblastoid, NB4 | ||||||||
Transcripts: | ENST00000409439, OTTHUMT00000109083, OTTHUMT00000239270, OTTHUMT00000333917, OTTHUMT00000333918, UC002CHM.2 | ||||||||
Position: |
|
RGD ID: | 7230795 | ||||||||
Promoter ID: | EPDNEW_H21143 | ||||||||
Type: | initiation region | ||||||||
Name: | PIGQ_2 | ||||||||
Description: | phosphatidylinositol glycan anchor biosynthesis class Q | ||||||||
SO ACC ID: | SO:0000170 | ||||||||
Source: | EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/) | ||||||||
Alternative Promoters: | null; see alsoEPDNEW_H21144 | ||||||||
Experiment Methods: | Single-end sequencing.; Paired-end sequencing. | ||||||||
Position: |
|
RGD ID: | 6793367 | ||||||||
Promoter ID: | HG_KWN:22622 | ||||||||
Type: | CpG-Island | ||||||||
SO ACC ID: | SO:0000170 | ||||||||
Source: | MPROMDB | ||||||||
Tissues & Cell Lines: | CD4+TCell_2Hour, K562, Lymphoblastoid, NB4 | ||||||||
Transcripts: | OTTHUMT00000333919 | ||||||||
Position: |
|
RGD ID: | 7230797 | ||||||||
Promoter ID: | EPDNEW_H21144 | ||||||||
Type: | initiation region | ||||||||
Name: | PIGQ_1 | ||||||||
Description: | phosphatidylinositol glycan anchor biosynthesis class Q | ||||||||
SO ACC ID: | SO:0000170 | ||||||||
Source: | EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/) | ||||||||
Alternative Promoters: | null; see alsoEPDNEW_H21143 | ||||||||
Experiment Methods: | Single-end sequencing. | ||||||||
Position: |
|
Database | Acc Id | Source(s) |
AGR Gene | HGNC:14135 | AgrOrtholog |
COSMIC | PIGQ | COSMIC |
Ensembl Genes | ENSG00000007541 | Ensembl, ENTREZGENE, UniProtKB/Swiss-Prot, UniProtKB/TrEMBL |
Ensembl Transcript | ENST00000026218 | ENTREZGENE |
ENST00000026218.9 | UniProtKB/Swiss-Prot | |
ENST00000293874 | UniProtKB/TrEMBL | |
ENST00000321878 | ENTREZGENE | |
ENST00000321878.10 | UniProtKB/Swiss-Prot | |
ENST00000409527.6 | UniProtKB/Swiss-Prot | |
ENST00000420990.6 | UniProtKB/TrEMBL | |
ENST00000422307.6 | UniProtKB/TrEMBL | |
ENST00000439574.1 | UniProtKB/TrEMBL | |
ENST00000443147.5 | UniProtKB/TrEMBL | |
ENST00000470411.2 | UniProtKB/Swiss-Prot | |
ENST00000540241.1 | UniProtKB/TrEMBL | |
ENST00000635205.1 | UniProtKB/TrEMBL | |
ENST00000635909.1 | UniProtKB/TrEMBL | |
ENST00000636005.1 | UniProtKB/TrEMBL | |
ENST00000636657.1 | UniProtKB/TrEMBL | |
ENST00000637468.1 | UniProtKB/TrEMBL | |
ENST00000638143.1 | UniProtKB/TrEMBL | |
GTEx | ENSG00000007541 | GTEx |
HGNC ID | HGNC:14135 | ENTREZGENE |
Human Proteome Map | PIGQ | Human Proteome Map |
InterPro | GlcNAc_Gpi1 | UniProtKB/Swiss-Prot, UniProtKB/TrEMBL |
KEGG Report | hsa:9091 | UniProtKB/Swiss-Prot |
NCBI Gene | 9091 | ENTREZGENE |
OMIM | 605754 | OMIM |
PANTHER | PHOSPHATIDYLINOSITOL N-ACETYLGLUCOSAMINYLTRANSFERASE SUBUNIT Q | UniProtKB/Swiss-Prot, UniProtKB/TrEMBL |
PTHR21329 | UniProtKB/Swiss-Prot, UniProtKB/TrEMBL | |
Pfam | Gpi1 | UniProtKB/Swiss-Prot, UniProtKB/TrEMBL |
PharmGKB | PA33299 | PharmGKB |
UniProt | A0A0U1RQX6_HUMAN | UniProtKB/TrEMBL |
A0A1B0GUF6_HUMAN | UniProtKB/TrEMBL | |
A0A1B0GUW1_HUMAN | UniProtKB/TrEMBL | |
A0A1B0GVF8_HUMAN | UniProtKB/TrEMBL | |
A0A1B0GVV7_HUMAN | UniProtKB/TrEMBL | |
A0A1B0GVY0_HUMAN | UniProtKB/TrEMBL | |
A2IDE1 | ENTREZGENE | |
B2RAU6 | ENTREZGENE, UniProtKB/TrEMBL | |
B8ZZ29_HUMAN | UniProtKB/TrEMBL | |
B8ZZ31_HUMAN | UniProtKB/TrEMBL | |
D3DU52 | ENTREZGENE | |
E7ERP4_HUMAN | UniProtKB/TrEMBL | |
H0YFM9_HUMAN | UniProtKB/TrEMBL | |
H7C336_HUMAN | UniProtKB/TrEMBL | |
J3QTH6_HUMAN | UniProtKB/TrEMBL | |
O14927 | ENTREZGENE | |
PIGQ_HUMAN | UniProtKB/Swiss-Prot | |
Q96G00 | ENTREZGENE | |
Q96S22 | ENTREZGENE | |
Q9BRB3 | ENTREZGENE | |
Q9UJH4 | ENTREZGENE | |
UniProt Secondary | A2IDE1 | UniProtKB/Swiss-Prot |
D3DU52 | UniProtKB/Swiss-Prot | |
O14927 | UniProtKB/Swiss-Prot | |
Q96G00 | UniProtKB/Swiss-Prot | |
Q96S22 | UniProtKB/Swiss-Prot | |
Q9UJH4 | UniProtKB/Swiss-Prot |
Date | Current Symbol | Current Name | Previous Symbol | Previous Name | Description | Reference | Status |
---|---|---|---|---|---|---|---|
2015-11-10 | PIGQ | phosphatidylinositol glycan anchor biosynthesis class Q | phosphatidylinositol glycan anchor biosynthesis, class Q | Symbol and/or name change | 5135510 | APPROVED |